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A ’blueprint’ of any organism is encoded in the DNA of every one of its cells. During develop-
ment, cells differentiate and become specific. The regulation of development, maintenance
of a certain state, and reaction to external impacts take place on chromatin. Chromatin
describes the organization of DNA, histones, and non-histone proteins [1]. Chromatin can
be separated into euchromatin and heterochromatin. Euchromatin describes areas with
loosely packed DNA, available for chromatin remodelers, transcription factors, and poly-
merases; these regions are transcriptionally active. In contrast, heterochromatin describes
well-ordered and densely packed DNA in fibers that is in general transcriptional silent [2]. The
nucleosome is known to be the smallest building block of chromatin’s highly complex and
dynamic structure [1].
1.2 Chromatin structure
1.2.1 The nucleosome core particle
The nucleosome core particle (NCP) is a complex of DNA wrapped in 1.65 turns around
an octameric core composed of a H3-H4 tetramer and two H2A-H2B dimers. Histones are
small, highly basic proteins that are conserved among species. All four histone types have
the histone fold in common that describes the folding of three α-helices connected by a
short loop region, together referred to as the globular domain. The α-helices form a ’u’-like
structure with the 1st and the 3rd α-helices stretching out of the plane in opposite directions,

























H2A  N-terminal tail
Figure 1.1: Crystal structure of the nucleosome core particle
Crystal structure of nucleosome core particle [3], PDB identification number:
1KX5. Histones and DNA are shown in yellow (H2A), red (H2B), blue (H3),
green (H4) and gray (DNA). (A) frontal view on the NCP. (B) 90◦ rotation of (A).
(C) Histone fold of H3 (blue) and H2A (yellow), α-helices 1-3 are shown on the
example of H3; N- and C-terminus are marked with N and C, respectively. (D)
Structure of H2A-H2B dimer within the NCP based on 1KX5. (E) Structure of
H3-H4 tetramer within the NCP based on 1KX5.
Several interactions between histones and DNA keep both components in place. For exam-
ple, ionic interactions of the phosphodiester backbone of the DNA, with lysine residues of the
histone globular domain. Hydrogen bonds stabilize the complex between DNA phosphates
and α-amides of amino acids within the α-helices of the histones, as well as non-polar inter-
actions of the deoxyribose with the histone [3;4].
The N-termini of all four histones and C-termini of H2A and H2B stick out of the nucleosome
core and can be accessed by nuclear proteins [3;4]. These histone tails are 20-30 amino acids
long, unstructured and carry a wide range of post-translational modifications [5].
2
1.3 POST-TRANSLATIONAL MODIFICATIONS OF HISTONES
In vivo, the NCP assembly process is regulated by chromatin assembly factors and histone
chaperones [6;7]. In vitro, the NCP can assemble without such factors and is thought to pro-
ceed via an all components detached state (DNA + H2A/H2B dimer + H3/H4 tetramer) over
an intermediate DNA-H3/H4 tetrasome, for which the H2A/H2B dimer associate to form the
NCP.
1.2.2 Chromatin folding in higher-order structures
The nucleosome has been found to be the smallest building block of chromatin and its highly
complex and dynamic structure. Here, the first layer of compaction is achieved by linear
arrangement of NCPs separated by 10-80 bp of linker DNA into a 11 nm high structure like
’beads on a string’ [8;9]. For the further organization of the 11 nm high structure based on
in vitro studies, two models have been proposed to form a 30 nm high fiber. The ‘selenoid’
model describes a scenario where the 11 nm high fiber is coiled around an axis of sym-
metry with slightly tilted NCPs connected by a DNA linker, thereby forming a ‘tube’ of 30 nm
high [10;11]. Another model proposes a zig-zag ribbon-like structure that forms a compact heli-
cal ribbon with NCPs arranged face-to-face [12;13]. However, a variety of 30 nm high structures
have been proposed based on in vitro and in situ studies. Less clear, however, is the picture
of chromatin folding beyond the 30 nm fiber, though it likely contains long-range interactions
and looping of chromatin fibers [14].
1.3 Post-translational modifications of histones
Up to date, there are many different known PTMs, e.g. modifications with rather small
moieties such as acetylation, methylation, phosphorylation and deamination, or larger moi-
eties such as ubiquitinylation, sumoylation, ADP-ribosylation, propylation and butylation [5].
Amongst the histones, H3 and H4 carry the most PTMs, whereas H2A possesses only few
modifications on its N-terminus. In addition, H2A and H4 have the first 5 amino acids in com-






phosphorylationH2ASGRGKQGGKT RAKAKTRSSR  
H3ARTKQTARKS TGGKAPRKQL ATKAARKSAP ATG
Figure 1.2: Selected histone modification of H3 and H2A
Globular domain of H3 (blue) and H2A (yellow) with sequence of N-terminal his-
tone tail. Modification sites used in this study are marked for acetylation, methy-
lation and phosphorylation with triangle, circle and diamond respectively.
1.3.1 Acetylation and phosphorylation
The acetylation of lysine residues is one of the longest known and most studied histone
modification [16;17]. It has been found to disrupt higher-order chromatin structure and to
facilitate transcription [18;19]. It is predominant in euchromatin and almost absent in hete-
rochromatin [20]. The existing positive charge is transformed via acetylation of the basic ly-
sine ε-amino group in the N-termini of histones, thus changing the affinity of the DNA to the
histones and generating loosely packed DNA that is available for transcription factors and
polymerases [21–23]. Additionally, the introduction of an acetyl-group provides a recognition
mark for proteins to interact with [20]. This mark is set by HATs, removed by HDACs, and read
by the bromo- and certain tandem-PHD-domains [24;25]. Acetylation of histones can be car-
ried out in two different modes. Some HATs acetylate nucleosomes target specific lysines,
while others acetylate rather globally, in an untargeted manner [26].
Table 1.1: Histone H2A and H3 modification and their associated function adapted from
Lawrence et al. [5]
Histone modification Associated function
H2AS1ph Mitosis
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Table 1.1 – continued from previous page







H3S10ph Mitosis, meiosis and transcriptional activation
H3T11ph/S28ph Mitosis
Abbreviatons:
H2A/H3 – histone H2A/H3
S – serine; K – lysine; T – threonine (followed by the residue number)
me2/3 – di-/tri methylation; ph – phosphorylation; ac – acetylation
H2A carries post-translational modification on the N-terminus: α-N-acetylation of H2AS1 and
ε-acetylation of H2AK5, H2AK9, H2AK13 and H2AK15 [27;28]. Whereas acetylation are ob-
served on H3 tails on basically every lysine residue, H3K4, H3K9, H3K14, H3K18, H3K23
and H3K27 are associated with transcriptional activation as summarized in table 1.1 [5]. While
acetylation neutralizes the positive charge of lysine residues, the phosphorylation of serines
or threonines introduces a negative charge. This influences the interaction with DNA, but also
provides an additional recognition mark for interacting with effector proteins [29]. Phosphory-
lation sites are in general serines, threonines and thyrosines. The mark is placed by kinases
and removed by phosphatases [30]. In the context of phosphorylated histones, the only do-
mains known to interact with phosphorylated serines and threonines are 14-3-3 proteins and
the BRCT domain [25;31]. Phosphorylations on histone H3 play a key role during mitosis by
regulating its neighbor availability for binding partners. Phosphorylation has been associated
with both transcription activation and silencing [29]. For example, HP1 binds H3K9me3, but
the phosphorylation of H3S10 disrupts this interaction [32;33]. During mitosis, the serine 1 of
H2A and H4 were found to be highly phosphorylated and less during S-phase [34]. Although
histone H2A and H4 have the first 5 amino acids in common, it was shown that S1ph of H4
and H2A occurred at different stages during the development of Xenopus laevis [15]. Fur-
thermore, phosphorylation together with acetylation on the same histone tail seems to have
an enhancing effect on the activity on HAT. For GCN5, an enhanced acetylation activity on




Methylation on lysine residues
Whereas acetylation is mainly found in transcriptionally active regions, methylation marks
are common in both eu- and heterochromatic structures [35]. In contrast to acetylation and
phosphorylation, methylation does not change the overall charge of the residue, but rather
provides different handles by mono-, di-, or tri-methylation of the ε-amino group of lysines.
Methyl marks are placed site-specifically by HKMTs. The first discovered HKMT was the hu-
man SUV39H1, which methylates H3K9, the docking site for HP1 [36;37]. Almost every HKMT
contains the catalytic SET domain which activates the methyl group from SAM and transfers
it to the lysine residue of histones [38]. The site selectivity and methylation degree is thereby
conveyed by the enzyme. Whether a HKMT only catalyzes the mono-methylated state or
the di- and tri-methylated states as well depends on the spatial properties of the catalytic
domain [37].
Removal of methylation marks is carried out by LSD, which are only able to remove mono-
and di-methyl marks, whereas Jumonji demethylases are able to remove all three methylation
states on lysines [38;39]. The mark is read by protein domains belonging to the royal superfam-
ily consisting of chromo, double chromo-, double and tandem tudor-, as well as MBT-domains
and the PHD-finger family. Whether these domains bind higher or lower methylation states of
lysines depends on their binding pocket. Here, selective recognition of tri-methylated lysine
residues is facilitated by stabilizing the target methylammounium group in an aromatic cage,
thus stabilizing its positive charge via π-interaction by these aromatic residues and additional
hydrophobic interactions [31]. In contrast, lower methylation states are stabilized within the
binding pocket via hydrogen bonds. Additionally, the binding pocket is rather small, guar-
anteeing the binding of lower modification states. Consequently, tri-methylated lysines that
demand large binding pockets are not recognized [31].
Abundant methylation sites on the histone H3 tail are K4, K9, K27, and K36 [40]. Methylation
of H3K4 hallmarks transcriptionally active chromatin. Nonetheless, in embryonic stem cells
the euchromatic mark H3K4me3 and the heterochromatic mark H3K27me3 are found to co-
exist in silenced chromatin and form bivalent domains [35].
Different methylation states seem to have different purposes. It was shown in mice for
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the methylation on lysine 9 of histone H3 that H3K9me3 is localized at pericentric hete-
rochromatin, whereas H3K9me1/2 are found in silenced euchromatin [41–43]. Additionally,
H3K27me2 is the predominant modification state in mouse embryonic stem cells, and is mu-
tually exclusive with the H3K27me1 that is present in the core of expressed genes and the
H3K27me3 that is connected to gene repression [44].
Methylation on arginine residues
Arginine residues can also be mono- and di-methylated at their guanidino group. The dimethy-
lated state occurs either on the same (asymmetric) or on two different (symmetric) nitrogens
of the guanidino group. The mark is placed by PRMTs using SAM as the methyl donor. There
are two types of PRMTs; both types are able to mono-methylate arginines. They differ in
their dimethylation product, whereas PRMT type I dimethylates arginines asymmetric (R2A),
type II PRMTs catalyze symmetric dimethylation marks (R2S) [38]. How the mark is removed
is not yet entirely clear. Unmethylated arginines can be deiminated by PADIs, resulting in
citrulline, thus preventing methylation. Whether Jumonji6 also has demethylase activity for
arginine was debated for quite some time. Recently, it was found that certain Jumonji lysine
demethylases are also able to demethylate arginines of histone peptides [45;46].
Asymmetric methylation of R3 of histone H2A and H4 is placed by PRMT1&6. This mark
has been linked to gene activation. In contrast, symmetric methylation of H2A/H4-R3 by
PRMT5&7 has been related to gene repression [45]. A study focusing on H2A arginine methy-
lation could show that only H2AR3me was incorporated into chromatin after fertilization but
not H2AR3me2S , both PTMs are placed by PRMT5 in the oozyte of Xenopus laevis [47].
1.4 Chromatin effector proteins
Post-translational modifications on histones can act in two ways on chromatin. Firstly, by
directly changing chromatin structure, and secondly, by recruiting effector proteins to chro-
matin, which in turn can have an indirect impact on chromatin structure [23;48;49]. Effector
proteins are classified by their impact on chromatin: (1) Chromatin remodeling complexes
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which are able to slide nucleosomes along the DNA in an ATP dependent manner. (2) Com-
plexes mediating stability for higher order chromatin structure and (3) Enzymes ‘writing’ or
‘erasing’ post-translational modifications [35;50].
1.4.1 Histone acetyltransferase: GCN5
Histone acetyltransferases have been studied since the 1970s and categorized into HATs
type A and B. While HATs type B are present in the cytoplasm and are acetylating free, de
novo synthesized histones, type A HATs are found in the nuclei of acetylated histones within
the nucleosome and are connected to transcriptional activation [20]. GCN5 is an A-type HAT
and the eponyme of the GNAT family (GCN5 related N-acetyltransferases) that shares highly
conserved features such as the HAT domain and an C-terminal bromo domain [26;51]. In Sac-
charomyces cervisiae GCN5 plays a role as a transcriptional co-activator in the activation of
certain genes by acetylating histones within the promotor region of target genes [52;53].
HAT BromoN C
100 255 344 4141 439
Figure 1.3: Domain organization of GCN5
Localization of histone acetyl transferase domain (HAT) 100-255 aa and the
acetylated–lysine-recognizing bromo domain (Bromo) 344-414 aa of GCN5 from
yeast with N- and C-terminus labeled with N and C, respectively.
The HAT domain of GCN5 catalyzes the transfer of the acetyl group from AcCoA to the
ε- amino group of the lysine residue via a tetrahedral intermediate. The nucleophilic attack of
AcCoA is initiated by deprotonation of the ε- amino group by E173 of GCN5 [54]. GCN5 first
binds AcCoA, and only then it does gain an affinity for H3 binding [26].
The bromo domain of GCN5 binds to acetylated lysine residues with rather low affinity
(KD = 1 mM), thereby favouring positively charged residues neighboring the binding site [55].
GCN5 binds 11 amino acids of the histone H3 tail from R8 to Q19. When H3S10 is phos-
phorylated H3T11 makes additional contacts with GCN5. On the H3 peptide level, GCN5
from Tetrahymena prefers substrates phosphorylated on H3S10 and acetylates H3K14 [56].
H3S10ph and H3K14ac together enhance the activity of GCN5. Certain promotors require
the independent binding of both the kinase responsible for phosphorylation and the HAT for
acetylation of histones for activation, while other promotors recruit the HAT in an H3S10ph-
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dependent manner [29;57].
In vitro GCN5 is found to be solely active on nucleosomes when it forms the SAGA (Spt-
Ada-GCN5 acetyltransferase) or the ADA complex (Ada-GCN5-acetlytransferase) [52]. Under
certain experimental in vitro conditions, however, recombinant GCN5 is found to acetylate
nucleosomes [58]. The SAGA complex preferentially hyperacetylates H3K4me3 nucleosomes
over unmodified H3K4. This has not been observed on the H3 peptide level. Within the SAGA
complex, recognition is carried out by the tandem Tudor domain of Sgf29. Enhancement in
H3K4me2-dependent hyperacetylation was only observed on the histone H3, whereas the
acetylation rate of histone H4 was unaffected [59]. A study by Cieniewicz et. al [60] with the
ADA complex revealed preferred histone acetylation: H3K14 > H3K23 > H3K9 ≈ H3K18 >
H3K27 > H3K36. Based on this study, a ‘two-step reader/writer’ model was suggested by
first acetylating H3K14, thereby recruiting the bromo domain of GCN5 to the histone tail and
then continuing acetylation of the remaining acetylation sites [60].
1.4.2 Kinase: Aurora B
The serine/threonine kinase Aurora was first identified in Drosophila melanogaster and is
conserved from yeast to mammals. Three Aurora kinases are known in mammals: Aurora A,
B, and C. Aurora A is localized to mitotic spindle poles while Aurora C functions similarly to
Aurora B and is mainly expressed in testis [61;62]. Aurora B together with INCENP, Borealin
and Survivin form the chromosomal passenger complex (CPC). Aurora B localizes during
mitosis with centromers, then moves to the midzone of the central spindle and finally posi-
tioning itself on the midbody of dividing cells [63;64]. In addition to its regulating role during
mitosis and cytokinesis, Aurora B has been found to be an active promoter in quiescent B
and T cells. By phosphorylating H3S28, Aurora B maintains transcription in quiescent B and
T cells [65].
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Figure 1.4: Domain organization of Aurora B kinase




In general, kinases are built in their catalytic domain either for the phosphorylation of ser-
ine/ threonine, or for tyrosine [66]. The catalytic domain accommodates the S/T or Y substrate
and ATP. With the help of Mg2+, ATP is orientated towards the substrate-enabling catalysis
of the transfer of the γ-phosphate to the hydroxy moiety of the substrate [66]. Aurora B is
activated by the binding to its complex partner INCENP and by phosphorylation of itself and
INCENP on its C-terminal TSS motif. Autophosphorylation is thought to occur in trans, thus
high concentration of Aurora B enhances the activation process [64]. The consensus target
sequence of Aurora kinases is [R/K]-X-[T/S]-[I/L/V]. On histone H3, Aurora B phosphorylates
accordingly within the RKS motif, although [I/L/V] are missing [63;68]. The CPC containing
Aurora B is recruited to chromatin via Survivin that recognizes H3T3ph [69]. Aurora B phos-
phorylates H3 site-specifically at H3S10 and H3S28. In addition to histone H3, Aurora B has
a variety of non-nucleosomal substrates [70;71].
1.4.3 Heterochromatin protein 1
The HP1 family is conserved from yeast to human. In several organisms, HP1 homologs
come in isoforms. In humans, three isoforms are known: HP1α, β, and γ. While HP1γ
is found in euchromatic regions, HP1α and β localize on chromosomes to pericentric hete-
rochromatin [33;72]. HP1s are considered a key player of regulating heterochromatin [73]. At
the beginning of mitosis, Aurora B phosphorylates H3S10 thus evicts HP1 from the preced-
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Figure 1.5: Domain organization of heterochromatin protein 1
Localization of chromo domain (CD) 21-79 aa, hinge region (H) 79-117 aa and
chromo shadow domain (CSD) 117-175 aa of human HP1β. N: N-terminus, C:
C-terminus.
hinge region. The N-terminal chromo domain recognizes H3K9me3, whereas the chromo
shadow domain is responsible for dimerization, hereby stabilizing and regulating higher or-
der chromatin structure. In addition, HP1 tethers other proteins via the chromo shadow
domain to chromatin containing a P-X-V-X-L recognition motif [74]. For example, HP1 recruits
the methyltransferase Su(var)3-9, which methylates H3K9 on proximate nucleosomes [75;76].
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Beside the two binding domains, the very N-terminal stretch of HP1β aids binding via unspe-
cific electrostatic interactions. Moreover, the flexible hinge region can interact unspecifically
with DNA, depending on its overall charge, which can be altered through post-translational
modification, overruling the H3K9um/H3K9me3 specific binding [75;77]. The binding of HP1 to
H3K9me3 is regulated by the phosphorylation of its neighbor H3S10 [33;78].
1.5 PTM cross-talk and multivalent readout
In order to shed light on the versatile post-translational modified histone tails and their dif-
ferent modification patterns, Strahl et al. [49] and Jenuwein and Allis [79] proposed the histone
code, envisioning that a specific set of PTMs on the histone tails lead to a distinct biologic
outcome by providing a platform for effector proteins. In addition to the histone code hy-
pothesis, Schreiber et al. [48] highlighted the similarities between the mechanisms of histones
conveying nuclear regulation and models of signal transduction that rely on robust signaling
by feedback loops and redundant signaling.
Histone PTM pattern are interpreted by effector proteins that determine the biologic out-
come [25]. PTM patterns on the histone tails are modified by enzymes that ‘write’ or ‘erase’
histone marks [80]. ‘Writer’ and ‘eraser’ need to be guided to the place of action; this is accom-
plished indirectly by effector proteins or directly by a binding domain of the enzyme that can
be recruited to specific areas of the chromatin depending on the PTM pattern displayed on
the histone tails [79]. For instance, H3K4me has been found in both activating and repressing
contexts. The idea was thus put forward that the trigger for recruiting activating or repressive
factors are multiple PTMs acting together, thereby influencing the recognition of effector pro-
teins in a synergistic or antagonistic manner [31;48]. The effector proteins/ complexes in turn
carry multiple domains/proteins which allow interaction with histone PTMs in a combinatorial
manner. For example, human TAF1 (TATA-binding protein associated factor-1) is composed
of multiple domains that recognize acetylated lysines, thereby gaining its affinity for hyper-
actelyated histone tails [35].
Taking a close look at histone modifications and their possible combinations, several lay-
ers of complexity would be possible. The most basic PTM cross-talk is observed between
modifications that target the same amino acid residue, e.g., the mutual exclusive modifica-
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tion of lysine residues by methylation or acetylation. Histone marks on the same histone
tail (cross-talk in cis) may influence each other. The special case of cross-talk between
adjacent amino residues has been found to be a general phenomenon and is termed as a
‘binary switch’, such as the ‘methyl/phos’ switch. This mechanism was first found for H3K9
and H3S10 [33;78]. Upon phosphorylation of H3S10, the binding of HP1 to H3K9me3 is abol-
ished. Consequently, more binary switches have been discovered, e.g. H3S28 and H3K27.
The phosphorylation of H3S28 disrupts the recruitment of its binding partner to methylated
H3K27 and induces the placement of acetylation [32;81;82]. Additionally, a methyl/phos-switch
was also observed for H3T3 regulating the availability of H3K4me1 [83]. Hence, recognition
’cassettes’ have been defined for which a maximum of 5 and minimum of 3 modified residues
are separated by only one unmodified amino acid. For example, the ‘RKS’ motif in H3 rep-
resents the immediate environment of H3K9 and H3K27 and is highly modified [23;84]. In
addition, the presence of one modification may enhance the activity of an enzyme for placing
another modification as it was observed for Tetrahymena GCN5 displaying enhanced H3K14
acetylation when H3S10 was phosphorylated [56].
Cross-talk of PTM residing on different histone tails (trans) is also possible, e.g. for BPTF
(bromodomain PHD finger transcription factor), part of the NURF (nucleosome remodeling
factor) complex, has been shown to interact simultaneously with H3K4me and H4K16ac.
All three components are associated with the regulation of transcriptional activity [85]. The
complexity of PTM cross-talk in trans can involve several histone modifications and effector
proteins. For instance, the serine/threonine kinase Haspin phosphorylates H3T3, thereby
recruiting the CPC containing Aurora B kinase that leads to the phosphorylation of H3S10.
H3S10ph recruits HDACs that remove the acetyl group on H4K16. This induces the H4 tail
to interact with the acidic patch of H2A and leads to condensed chromatin [86].
The investigation of asymmetric PTM cross-talk, i.e. the study of differentially modified hi-
stone tails of the same histone type within the same nucleosome, revealed that the hete-
rochromatic mark H3K27me3 and the euchromatic mark H3K4me3 in bivalent chromatin are
located on different histone tails within the same nucleosome [87]. Recent single molecule in
vivo studies in embryonic stem cells refined the picture of bivalent chromatin. They found
that the majority of bivalent modification patterns occur in an asymmetric manner but a small
fraction of NCPs present symmetric modification patterns [88].
Here, only a few examples for PTM cross-talk in cis and in trans were mentioned, already
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indicating a direction of high complexity within one histone tail. The complexity potentiates
within the nucleosome that is eventually responsible for the regulation of life.
1.6 Techniques for studying histone PTMs
There are several tools available in the field for studying histone marks in vitro and in vivo.
They can be distinguished by the choice of chromatin template and what sort of information
they deliver. Most in vitro studies work with the histone tail peptide. They are the simplest
archetype of the chromatin system when only histone modifications in cis are of interest.
Here, PTMs are easy to introduce by SPPS. Thus, combinatorial studies are feasible. For
studying PTM in cis and trans, suitable surrogates of chromatin are mono-nucleosomes or
nucleosome arrays. The modified templates are more difficult to procure. In general, the
modification is introduced at the histone level, followed by nucleosome reconstitution.
1.6.1 Generating modified histones – semisynthetic approaches
Native chemical ligation (NCL) has been the most powerful tool in synthesizing a wide range
of proteins [89;90]. It has been applied on histones for introducing site-specific modified histone
tails. NCL works in aqueous solvents, neutral pH environments and under denaturing condi-
tions. The only requirement is an N-terminal cysteine that requires recombinant integration
at the desired ligation site on the histone. The PTM decorated histone tail with a C-terminal
thioester is synthesized by SPPS [89;91].
Mechanistically, expressed protein ligation (EPL) works similarly to NCL. Both techniques rely
on the formation of a thioester, a transesterification, and a native peptide bond. By means
of EPL, it is however possible to work with native, fully folded proteins. Here, a protein (in-
tein) is expressed between two other protein domains (exteins) that catalyse the ligation and
formation of a native peptide bond between both terminal exteins (figure 1.6 (A)). The mech-
anism relies on the formation of a thioester via an N → S acyl shift at the C-terminus of the
N-terminal extein (Extn), followed by a nucleophilic attack of the cysteine of the C-terminal
extein (Extc), thereby transferring the ester. The subsequent irreversible rearrangement of
















































































































Figure 1.6: Protein trans-splicing and Sortase A mediated ligation
Reaction mechanism of protein trans-splicing and Sortase A (SrtA) mediated
ligation. (A) Peptide and POI (protein of interest) requirements for protein trans-
splicing (PtS) and resulting splice product. Abbreviations are for ExtN : N-
terminal extein, IntN : N-terminal intein, IntC : C-terminal intein and ExtC : C-
terminal extein. Sequence requirements are at position -1: G, +1: S, +2: I and
+3: E. Ligation scar depicted in grey: GSIE. (B) Mechanism of PtS in 5 steps: in-
tein formation, N-S acylshift, transesterification, irreversible succinimid formation
and final restoring of the native peptide bond by O-N acylshift. (C) Mechanism of
SrtA mediated ligation and requirements for peptide: LPxTG sequence and POI:
N-terminal G. Threonine of the peptide is activated by formation of SrtA-peptide
thiosester that is attacked by the N-terminal nucleophile (glycin) of POI.
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connected via a native peptide bond (figure 1.6 (B)) [92].
This technique became interesting for protein engineering by the discovery and development
of mini split inteins [93]. As the name implies, the intein also works when it is split in two;
upon combining both parts, it catalyses the formation of the native peptide bond in trans
between its flanking exteins. Hence, it is referred to as protein trans-splicing (PtS). Natu-
rally occurring inteins have their split site in the middle, close to the homing endonuclease
domain, which is a common feature among inteins, but is dispensable for the ligation. Split
mini inteins were engineered in such a manner so that either the N- or C- terminus has a
short peptide sequence that can be easily synthesized via SPPS to label proteins with dyes
or short peptide sequences [93;94]. PtS has also been used in vivo for labeling histone H2B
C- terminal with a dye, peptide-tag or for introducing it into isolated nuclei the C-terminal tail
of H2B ubiquitinylated at K120 [95]. Appleby-Tagoe et al. [96] set out to optimize the splicing
efficiency and sequence requirements for the Ssp DnaB mini intein (intein from Synechocys-
tis species within the DnaB gene) using sequentially directed evolution. They found a mutant
(M86) with mutations throughout the entire intein that led to improved splicing and accepted
different amino acids at the -1 position (last amino acid of ExtN , one before the intein, see
figure 1.6 (A)). This is of special importance because it remains in the final splice product.
Nevertheless, some extein site requirements remain. At the -1 position of ExtN , amino acids
with small side chains are favored (G, A). In contrast, at the ExtC at +1, the catalytic S is
indispensable. Additional I and E at +2 an +3 are a great benefit for effective splicing [96;97].
Another semisynthetic strategy to ligate peptides to proteins via a native peptide bond relies
on the use of enzymes. One of these enzymes is the transpeptidase Sortase A (SrtA) of
Staphylococcus aureus. In S. Aureus SrtA mediates the attachment of surface proteins to
the cell wall by the recognition of a short peptide sequence LPxTG within the target. Srt A
activates the carboxy-group of the threonine via the formation of a thioester by generating a
substrate-enzyme intermediate. In a second step, the N-terminal glycine of the protein (or
peptide) to be ligated serves as a nucleophile and forms the native peptide bond [98;99]. SrtA
was subjected to optimization in terms of the recognition sequence by phage display. The
F40 mutant selectively recognized a new motif APxTG, which happens to be native within
histone H3. However, efficient ligation is only achieved after 24 hours [99].
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1.6.2 Advances in studying PTMs in the context of histone tail peptide or
full-length proteins
Several techniques have been developed for studying the binding properties of either spe-
cific histone tail modifications or specific PTM binding domains. For the screening of binding
domains on several histone PTMs, the high-throughput screening method SPOTblot was
developed. Using this, modified histone peptides are immobilized on a membrane. The
membrane is probed with the his-tagged binding domain of interest and binding events are
detected using antibodies against the his-tag of the bound domain [100;101].
Chromatin associated domain array (CADOR) is a complementary approach in studying
binding partners of specific histone marks. Here, reader domains are fused via GST onto a
glass slide, probed with synthetic histone tails carrying different modifications and a fluoro-
genic probe is used for the readout [102;103].
A homogeneous enzymatic assay using LANCE and ALPHA technology was adopted for
studying methyltransferase activity on modified H3 peptide and full-length protein [104–106].
Both techniques rely on antibody recognition of the substrate. Using LANCE technology,
the readout depends on TR-FRET. Hence, the antibody against the modification of interest
is modified with Europium that serves as a FRET Donor. The substrate, e.g. histone pep-
tide, is linked to a FRET acceptor bead. If the modification of interest has been placed by
the enzyme to be investigated, an antibody against this modification coupled to the FRET
donor would recognize it. This way, the FRET donor and acceptor are localized within the
FRET radius, which allows upon excitation of the donor bead detection of the signal emitted
by the FRET-acceptor. Similarly, ALPHA depends on two antibodies against the substrate,
each against a different epitope. The antibodies are additionally linked either with the ac-
ceptor bead or a biotin-tag, thereby inserting a handle for the donor bead. In contrast to
FRET-based assays, the donor bead here releases singlet oxygen that emits light from the
acceptor bead that is of shorter wave length than is used for the excitation of the donor bead.
Using this readout technology, beads can be up to 200 nm apart from each other before sin-
glet oxygen relaxes [104].
Garske et al. [107] developed an ’on bead screening’ assay. The authors synthesized a H3-
peptide [108] and H4-peptide [107] library with 50000 and 800 different modification patterns im-
mobilized on beads, respectively. The whole library is then presented a GST-tagged reader
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domain in direct competition for all modifications. Using the dimerization property of GST,
GST-tagged alkaline phosphatase is added, which upon the addition of bromo-4-chloroindlyl
phosphate results in a blue precipitate. Such detected positive hits are selected for mass
spectrometry in order to determine the PTM pattern of the histone tail.
As these techniques used histone peptides or full-length protein, precise but only limited in-
formation could be gained. More importantly, several chromatin effector proteins have been
shown to interact differently with histone peptides than with nucleosomes [59;109;110].
Techniques for studying PTM cross-talk
Mass spectrometry has been a very powerful tool in detecting PTMs on histones in an un-
biased manner. Using top-down (analyzing intact histones/proteins), middle-up (large frag-
ments of ∼ 5 kDa are subjected for MS analysis) and bottom-up (analyzing small fragments
of histones/proteins via MS) MS strategies identify an ever growing number of PTMs on his-
tones [5;42]. Top down experiments using SILAC (stable isotope labeling by amino acids in cell
culture) provide a great overview of proteins that interact with a specific set of modifications.
This has been accomplished on the histone peptide level as well as on mono-nucleosomes
and the nucleosome array level by performing a pulldown experiment in heavyisotope la-
beled and unlabeled nuclear extract [110–113]. Thus, it is possible using SILAC to screen for
modifications within a chromatin array in a combinatorial manner, but this is very costly and
time-consuming and requires advanced instrumentation. Nevertheless, this has been per-
formed for selected modifications [110;112].
A very interesting technique named BICON (biotinylation assisted isolation of co-modified nu-
cleosomes) was developed by Lau and Cheung [114]. As the name implies, BICON searches
for nucleosomes modified in vivo using an enzyme of interest (in this study, MSK1 (mitogen-
and stress-activated protein kinase-1)). Using the enzyme BirA, which biotinylates a short
recognition sequence of 15 amino acids, they were able to introduce the recognition se-
quence C-terminal to H3.3, the target of MSK1. The fusion of both enzymes MSK1 and BirA
leads to biotinylation of those H3.3 histones that are targeted by MSK1, which facilitates ex-
tracting modified nucleosomes, which are analyzed using antibodies against the modification
of interest.
Nguyen et al. [115] developed a technique for studying PTM cross-talk in cis. They introduce
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a method for studying the combinatorial readout of histone modifications within the context
of nucleosomes by chromatin ‘readers’ and ‘writers’. The authors develop a shortcut for the
reconstitution of NCP in order to build up an NCP library of 40 members with different mod-
ification patterns on all four histone types. In addition, they introduce a ’bar code’ label at
the DNA coded for the modification patterns of the NCP. After incubation of the whole NCP
library with a ‘reader’ or ‘writer’ protein, the authors perform immunoprecipitation against
a modification placed by the ‘writer’ of interest for analyzing its NCP modification. Affinity
purification is used for the identification of preferred NCP modification patterns for ‘reader’
proteins. Subsequent DNA sequencing of immunoprecipitated or affinity purified NCP reveal
the ’bar code’ and thereby the nucleosome modification pattern.
These techniques are very powerful in their analysis of PTM in the context of nucleosomes,
but they either require high-end instrumentation or depend on antibodies recognizing PTMs
in the context of nucleosomes. In addition, working with predefined chromatin templates
(NCP or nucleosome arrays) requires they be separately assembled for each modification
pattern.
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1.7 Objective of this study
In recent years, several in vivo and in vitro techniques were developed for studying the de-
pendence of PTM on chromatin function. These combinatorial studies were conducted using
histone peptides and selected PTM patterns were investigated in vitro using recombinant
mono- and oligo- nucleosomes as well as chromatin arrays. These studies revealed that in
several cases, effector proteins act differently on isolated histone peptides as compared to
mono-nucleosomes and chromatin arrays. However, several techniques relied on the use
of antibodies that limited the application because of their performance and availability or de-
pended on sophisticated equipment. For these reasons, we set out to develop tools for study-
ing combinatorial histone PTM patterns in the context of nucleosomes in a high-throughput
approach. In addition, we hypothesized that the interaction of ‘reader’ and ‘writer’ with NCP
is fine-tuned by certain PTM patterns presented by the NCP.
To address this, we set up an NCP library consisting of histone modification patterns in a
combinatorial manner. We thus aimed to reduce the number of NCP assemblies neces-
sary for the generation of modified NCP libraries to one single assembly. To do so, we
developed a ligation-ready nucleosome to which histone tails can be attached in a histone
type- and site-specific manner, thus allowing the introduction of various modifications. More-
over, we intended to establish a workflow which would allow us to perform the attachment of
PTM-decorated histone tails to the immobilized, ligation-ready NCP directly in the plate. To
address the question of whether additional modifications on NCPs would fine-tune the inter-
action with chromatin ‘reader’ and ‘writer’, we derived an assay with a fluorescence readout
for ‘reader’ and a radioactive proximity readout for ‘writer’ using the immobilized, combinato-
rial post-translational modified NCP library.
The work presented here is the first attempt to generate an immobilized, combinatorial mod-
ified NCP library by introducing the modification to the assembled NCP and the development
of an assay for analyzing the impact of histone PTM on the chromatin ‘reader’ and ‘writer’.
This study provides a potentially powerful tool for gaining insight into the complex regulation
of chromatin by PTM cross-talk.
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2 Material and methods
2.1 Material and reagents
Laboratory equipment used in this study is listed in table 2.1. Chemicals and media used for
experiments and protein expression are listed in table 2.2. Radiochemicals for biochemical
assays are listed in table 2.3. Commercial enzymes used for cloning and enzymatic experi-
ments are found in table 2.4. Consumables, commercial kits and chromatographic equipment
are listed in table 2.5. Primary and secondary antibodies including used dilutions are sorted
in table 2.6. Peptides used for peptide pull-down and initial H2A ligation experiments are
listed in table 2.7. Information for plasmids an their source are summarized in table 2.8.
Details of bacterial strains for cloning and expression can be found in table 2.9.
Table 2.1: Laboratory equipment
Equipment Supplier
ÄKTA Purifier/ Explorer GE Healthcare, Buckinghamshire (UK)
Balances Mettler-Toledo, Gießen
Centrifuge Sorvall Discovery M150 Thermo Scientific, Braunschweig
Centrifuge Sorvall Evolution RC Thermo Scientific, Braunschweig
Centrifuges 5415R/ 5810R Eppendorf, Hamburg
EmulsiFlex-C5 High Pressure Homogenizer Avestin, Ottawa (Canada)
ChemiDoc Bio-Rad, München
Heraues Kelvitron Incubator Thermo Scientific, Braunschweig
Hybridization oven GE Healthcare, Buckinghamshire (UK)
Infinite M1000Pro TECAN, Männedorf (CHE)
MiniTrans-Blot Bio-Rad, München
NanoDrop ND-1000 Peqlab, Erlangen
PCR thermocycler epgradientS Eppendorf, Hamburg
Peristaltic pump Ismatec, Glattbrugg (CHE)
pH meter Mettler-Toledo, Gießen
Plate reader Chameleon V Hidex, Turku (FIN)
Power supplies Bio-Rad, München
SpeedVac Savant SPD131DDA Thermo Scientific, Braunschweig
Stuart Gyrorocker SSL3 Sigma, Steinheim
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Table 2.1 – continued from previous page
Equipment Supplier
Sub-Cell-GT Agarose gel electrophoresis Bio-Rad, München
Thermomixer comfort Eppendorf, Hamburg
UV Transilluminator Bio-Rad, München
Waterbath TW12 Julabo, Seelbach
Table 2.2: Chemicals and media used for experiments and protein expression
Chemical Supplier
2 x YT medium Roth, Karlsruhe
2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
(HEPES)
VWR, Radnor PA (USA)
2-Mercaptoethanol Sigma, Steinheim
3-(N-Morpholino)propanesulfonic acid (MOPS) VWR international, Poole (UK)
β-glycerophosphate AppliChem, Darmstadt
Acetic acid Merck, Darmstadt
Acetyl coenzyme A (AcCoA) Roche, Mannheim
Acrylamid/ Bisacrylamid solution (37.5:1) Merck, Darmstadt
Adenosine 5’-triphosphate, disodium salt (ATP) Sigma, Steinheim
Agar Roth, Karlsruhe
Agarose Serva, Heidelberg
Amberlite MB3 resin Merck, Darmstadt
Ammonium persulfate (APS) AppliChem, Darmstadt
Ampicillin Roth, Karlsruhe
Benzamidin hydrochloride Sigma, Steinheim
Boric acid Merck, Darmstadt
Bovine serum albumin (BSA) Sigma, Steinheim
Bromphenol blue Serva, Heidelberg
Chlormaphenicol Sigma, Steinheim
Coomassie brilliant blue (CBB) Bio-Rad, Hercules CA (USA)
Deoxynucleoside-5’-triphosphate (dATP, dCTP, dGTP, dTTP) Roth, Karlsruhe
Di-sodium hydrogen phosphate (Na2HPO4) Merck, Darmstadt
Dimethylsulfoxide (DMSO) Sigma, Steinheim
Dithiothreithol (DTT) AppliChem, Darmstadt
Ethanol Merck, Darmstadt
Ethidium bromid solution (EtBr) Roth, Karlsruhe







Guanidine hydrochlorid Sigma, Steinheim
Hydrochloric acid (HCl) Merck, Darmstadt
Imidazole Roth, Karlsruhe
Isopropyl-βD-thiogalacto-pyranoside (IPTG) AppliChem, Darmstadt
LB Broth Dianova, Hamburg
Magnesium chloride hexahydrate (MgCl2 6·H2O) Merck, Darmstadt
Methanol Merck, Darmstadt
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Table 2.2 – continued from previous page
Chemical Supplier
Milk powder Roth, Karlsruhe
Nonident P-40 (NP-40) Roche, Mannheim
Phenylmethylsulfonylfluorid (PMSF) Sigma, Steinheim
Polyethylen glycol 6000 (PEG 6000) Merck, Darmstadt
Ponceau S Sigma, Steinheim
Potassium chloride (KCl) Merck, Darmstadt
Potassium di-hydorigen phosphate (KH2PO4) Roth, Karlsruhe
Protease inhibitor EDTA free Roche, Mannheim
Sodium azide (NaN3) Alfa Aesar, Massachusetts (USA)
Sodium chloride (NaCl) Merck, Darmstadt
Sodium di-hydrogen phosphate (NaH2PO4) Merck, Darmstadt
Sodium dodecyl sulfate (SDS), ultra pure Roth, Karlsruhe
Tetramethylethylendiamine (TEMED) Sigma, Steinheim
Triethanolamine (N(EtOH)3) VWR, Fontenay-sous-Bois (F)
Tris(hydroxymethyl)amino-methane (TRIS base) Roth, Karlsruhe




Yeast extract MOBIO, Hamburg










60 0.02 Perkin Elmer NEC313050UC
[γ-32P]-ATP 3000 10 Perkin Elmer BLU002A001MC
Table 2.4: Commercial enzymes used for cloning and enzymatic experiments
Name Supplier
Antarctic phosphatase New England Biolabs, Frankfurt/Main
DNase I New England Biolabs, Frankfurt/Main
Pfu DNA polymerase Fermentas/Thermo Fischer, Schwerte
PfuUltra II Fusion HS polymerase New England Biolabs, Frankfurt/Main
Q5 High-Fidelity DNA Polymerase New England Biolabs, Frankfurt/Main
Restriction enzymes New England Biolabs, Frankfurt/Main
T4 DNA ligase New England Biolabs, Frankfurt/Main
Taq polymerase (home made) purified by Sebastian David (MPI für biophysikalische
Chemie)
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Table 2.5: Consumables, commercial kits, and chromatographic equipment
Name Supplier
1 Kb Plus DNA ladder Invitrogen, Karlsruhe
Amberlite MB3 resin Merck, Darmstadt
Amicon Ultra centrifugal filter devices (MWCO
3,10,30 kDa)
Millipore, Tullagreen (IRL)
ECL Plus Western Blotting Detection System GE Healthcare, Buckinghamshire (UK)
ECL Western Blotting Detection Reagent GE Healthcare, Buckinghamshire (UK)
FlashPlate Plus, Streptavidin 96-well scintillant
coated microplate
Perkin Elmer, Shelton CT (USA)
HiLoad Superdex 200 PG 16/60 GE Healthcare, Little Chalfont (UK)
Ni2+-NTA agarose Qiagen, Hilden
Nitrocllulose membrane GE Healthcare, Little Chalfont (UK)
NucleoBond Xtra Midi Plus Machery & Nagel, Düren
NucleoSpin® Gel and PCR Clean-up Machery & Nagel, Düren
NucleoSpin® Plasmid Machery & Nagel, Düren
Pierce™ Streptavidin Coated High Capacity
Plates, Black, 96-Well
Pierce, Thermo Fischer Rockford IL (USA)
Q-Sepharose XK26/20 GE Healthcare, Little Chalfont (UK)
SeeBlue Plus2 prestained protein standard Invitrogen, Karlsruhe
Slide-A-Lyzer dialysis units (MWCO 3,500 and
10,000; volume 0.5 mL)
Thermo Fisher, Rockford IL (USA)
SP-Sepharose XK26/20 GE Healthcare, Little Chalfont (UK)
Spectra/Por Dialysis Membrane (MWCO 3,500
and 6-8,000)





Superdex 200 10/300 GL GE Healthcare, Little Chalfont (UK)
Table 2.6: Primary and secondary antibodies used for western blot analysis
Name Host Vendor/Catalog # Dilution
Primary antibodies
α-GFP mouse, monoclonal Santa Cruz / sc9996 1:5000
α-histone H2A rabbit, polyclonal Abcam / ab88770 1:1000
α-histone H3 rabbit, polyclonal Abcam / ab1791 and ab1781 1:10000
α-histone H3K9me2 mouse, monoclonal Abcam / ab1220 1:5000
α-histone H3K9me3 rabbit, polyclonal Upstate/Millipore / 07-442 1:1000
α-histone H4 rabbit, polyclonal Active Motif / 39269 1:1000
α-HP1β mouse, monoclonal Millipore / MAB3448 1:5000
Secondary antibodies
α-mouse Alexa 488 goat, polyclonal Invitrogen / A11001 1:5000
α-mouse HRP goat, polyclonal Dako / P0447 1:5000
α-rabbit Alexa 488 donkey, polyclonal Invitrogen / A21206 1:5000
α-rabbit HRP swine, polyclonal Dako / P0399 1:5000
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Table 2.7: Peptides used for peptide pull-down experiments and ligation of H2A
Name Sequence Source




P. Henklein, Charité, Berlin
H3-Btn ARTKQTARKSTGGKA PRKQL-Btn P. Henklein, Charité, Berlin
H3K9me3-Btn ARTKQTARKme2STGGKA PRKQL-Btn P. Henklein, Charité, Berlin
Table 2.8: Plasmids used for PCR and bacterial expression
Vector-Insert Restriction site Purpose Source
pBluescript II KS(+)
1x601
Not I/EcoRV template for HindIII-
EcoRI-EcoRV-147






BamHI/XhoI template for ’147’-DNA H. Mahler
pET16b His6-Aurora B NdeI/BamHI bacterial expression H. Mahler
pET16b
His6-Cerulean-HP1β
NdeI/BamHI bacterial expression H. Mahler
pET16b His6-eCFP-HP1β NdeI/BamHI bacterial expression/
template for
mutagenesis










NdeI/BamHI bacterial expression H. Mahler
pET3a H2A NdeI/BamHI bacterial expression K. Luger, Colorado State
University, Fort Collins
(USA)
pET3a H2B NdeI/BamHI bacterial expression K. Luger, Colorado State
University, Fort Collins
(USA)
pET3a H3 NdeI/BamHI bacterial expression K. Luger, Colorado State
University, Fort Collins
(USA)
pET3a H3∆1-32 NdeI/XhoI bacterial expression D. Schwarzer, Eberhard
Karls Universität Tübingen
pET3a H4 NdeI/BamHI bacterial expression K. Luger, Colorado State
University, Fort Collins
(USA)
pET3a IntC-H2A NdeI/BamHI bacterial expression H. Mahler
pIT021 IntC SspDnaB
M86
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Table 2.8 – continued from previous page
Name Restriction site Purpose Source




Table 2.9: Bacterial strains used for expression and cloning
Strain Genotype Supplier
Nova Blue E.coli endA1 hsdR17 (rK12− mK12+) supE44




BL21 (DE3) RIL E. coli B F-ompT hsdS(rB− mB−) dcm+ Tetr gal l
(DE3) endA The [argU ileY leuW CamR]
Stratagene, La Jolla
(USA)




2.2 Molecular biology methods
2.2.1 Determination of DNA concentration
The concentration of DNA was determined by measuring the absorbance at 260 nm against
a blank control with the NanoDrop ND1000. The relation of A260 = 1 = 50µg/mL double
stranded DNA was applied [117].
2.2.2 Transformation of E. coli strains
Chemically competent cells were transformed as described by Sambrook et al. [118]. 50µL
of chemically competent cells were thawed on ice and incubated on ice with 0.5-5µL DNA
plasmid for 20 min. Heat shock was applied for 45 sec at 42◦C and subsequently placed on
ice for 2 min. 250µL SOC media (2 % [w/v] tryptone, 0.5 % [w/v] yeast extract, 10 mM NaCl,
2.5 mM KCl, 20 mM glucose) was added and incubated for 1 h at 37◦C. In case of a transfor-
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mation with fresh ligated material, all cells were taken otherwise only 20-50µL and spread
out on a selection plate carrying ampicillin and incubated over night at 37◦C.
2.2.3 Agarose gel electrophoresis
For analyzing the quality of PCR products or NCP, agarose gel electrophoresis was per-
formed [119]. The gel was prepared with 1 % agarose [w/v] in 1 x TBE (89 mM TRIS base,
89 mM boric acid, 2 mM EDTA pH 8.0) supplemented with EtBr or 0.2 x TB (18 mM TRIS
base, 18 mM boric acid) without EtBr. Samples were set up by adding 6 x DNA loading buffer
(18 % [v/v] glycerol, 6 mM EDTA, 0.15 % [w/v] bromophenol blue) to final 1 x concentration.
Running along with 7µL of 1 kb plus DNA ladder, samples were separated depending on their
size by applying 100-120 V for 35 min at RT (PCR products) or at 100-120 V for 90-120 min
at 4◦C (NCPs). In case of NCP analysis, agarose gels needed to be stained post run with
0.1µg/mL EtBr in 0.2 x TB buffer for 10 min at RT, washed for 15 min with ddH2O. EtBr stained
agarose gels were analyzed under UV using an photo imager system. The efficiency of the
PCR for generating ‘147’ Widom 601 nucleosome positioning sequence was evaluated by
in-gel Cy5-fluorescence. This way, surplus Cy5-labeled oligonucleotides can be detected.
2.2.4 Site-directed mutagenesis
For obtaining the eCFP-HP1 derivatives mCFP- (eCFP A206K, monomeric) and Cerulean-
HP1 (eCFP S72A/Y145A/H148D, weak dimer), their DNA coding sequence was generated
by site directed mutagenesis [120] of pET16b-eCFP-HP1 for bacterial expression. The PCR
was performed in total volume of 50µL with 1xQ5 polymerase buffer, 50µM dNTPs, 20 nM of
each primer and 25 ng DNA template (pET16b eCFP-HP1) and 1 U Q5 polymerase using the
in table 2.10 described PCR program. With this strategy, pET16b mCFP-HP1 was generated
in one step, pET16b-Cerulean HP1 was performed in two. First step, site directed mutagen-
esis was performed for obtaining pET16b eCFP-Y145H Y148D and pET16b eCFP. The PCR
product was purified using the commercial NucleoSpin Gel and PCR Clean Up kit. Purified
plasmids were digested with the restriction enzyme DpnI for 1 h at 37◦C to destroy the tem-
plate produced originally by E.coli. Chemically competent E.Coli were transformed with the
mutation bearing, PCR generated plasmid as described before (chapter 2.2.2). Three to five
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colonies were picked and raised in mini culture of 5 mL LB medium (1:1000 ampicillin, stock
100µg/mL) at 37◦C, ON and 130 rpm shaking. From these mini cultures, plasmids were iso-
lated using the NculeoSpin Plasmid kit and sent for sequencing (SeqLab Göttingen). In the
second step, the final mutation was inserted for obtaining pET16b Cerulean-HP1. Herefor,
positive pET16b eCFP-Y145H Y148D clones served as DNA template for the final eCFP-
Y145H/Y148D/S72A mutation to obtain pET16b-Cerulean-HP1 using site directed directed
mutagenesis as described.








Table 2.11: Primer for site-directed mutagenesis
Name Sequence
Fwd eCFP A206K 5’-GCACCCAGTCCAAACTGAGCAAGACCCCAACGAGAAGCG-3’
Rev eCFP A206K 5’-CTTTGCTCAGTTTGGACTGGGTGCTCAGGTAGTGGTTGTC-3’
Fwd eCFP S72A 5’-GCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCAC-3’
Rev eCFP S72A 5’-CGGGGTAGCGGGCGAAGCACTGCACGCCCCAGGTCAGGG-3’
Fwd eCFP Y145A H148D 5’-GAGTACAACGCCATCAGCGACAACGTCTATATCACCGCC-3’
Rev eCFP Y145A H148D 5’-GACGTTGTCGCTGATGGCGTTGTACTCCAGCTTGTGCCCC-3’
2.2.5 Fusion PCR
In order to obtain IntC-H2A∆1−18 fusion protein for bacterial expression, DNA constructs
coding for IntC-H2A were generated by two step fusion PCR [121]. In the first step, DNA con-
structs coding for each protein IntC (template vector: pIT021 IintC Ssp DnaB) and H2A∆1−18
(template vector pET3a H2A) were generated separately with a sequence overlap at the joint
(IntC 3’ overlap H2A and H2A 5’ overlap with IntC) using the primer listed in table 2.13 and
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the PCR program shown in table 2.12. DNA insert IntC and H2A∆1−18 were purified from
PCR reaction mix using NucleoSpin Gel and PCR Clean Up kit.
In a second step, both DNA constructs IntC and H2A∆1−18 were mixed equal molar and
served as DNA template for the fusion DNA construct IntC-SIE-H2A∆1−18 using the primer
listed in table 2.13 and the PCR program shown in table 2.12. The DNA fusion insert IntC-
SIE-H2A∆1−18 and the target vector (pET16b) were digested with the restriction enzymes
NcoI and BamHI-HF for 1 h at 37◦C. The vector was additionally dephosphorylated with
antarctic phosphatase for 1 h at 37◦C. Then, DNA insert and vector were gel purified and
set up for ligation by T4 DNA ligase ON at 16◦C in a 4:1 molar ratio (insert:vector).








Table 2.13: Primer for fusion PCR
Name Sequence Insert
Fwd NcoI M86 5’-GAGATCCCATGGGCACTAGTAGC-3’ IntC
Rev M86 H2A 2 5’-GAGATTCGATGGAGTTATGGACAATGATGTC-3’
Fwd M86 H2A 5’-CTCCATCGAATCTCGGGCTGGGCTAC-3’ H2A∆1−18
Rev BamHI H2A 5’-GATCTCGGATCCTCACTTGCTCTTGGC-3’
Fwd NcoI M86 5’-GAGATCCCATGGGCACTAGTAGC-3’ IntC-SIE-H2A∆1−18
Rev BamHI H2A 5’-GATCTCGGATCCTCACTTGCTCTTGGC-3’
Chemically competent cells were transformed with 5µL of the ligation mix as described in
chapter 2.2.2. 3-5 colonies were cultured in 5 mL LB supplemented with ampicillin at 37◦C,
ON and 130 rpm shaking. Plasmids were isolated from mini-culture (NucleoSpin Gel and
PCR Clean Up kit) and the DNA digest was performed with 800 ng plasmid and 0.5µL of
each restriction enzyme (NdeI/BamHI) for 30-60 min at 37◦C and analyzed using agarose
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gel electrophoresis as described in chapter 2.2.3. Plasmids carrying the expected insert size
were sent for sequencing to Seqlab Göttingen using primer from their standard primer list
(T7term).
2.2.6 Generation of biotinylated and Cy5-labeled ‘147’ Widom 601 DNA
template
The DNA template used in this study had several modifications from the original 147 base
pair Widom 601 positioning sequence [122]. Firstly, it was extended at the 5’- end containing
the sequence for three different restriction enzymes: HindIII, EcoRI and EcoRV using the
fwd-template primer. Secondly, a Btn-tag was linked via a Tg-linker to the 5’ end of the
‘147’ sequence and thirdly, the fluorogenic probe Cy5 was attached to the 3’- end of the ‘147’
sequence. Biotin- and Cy5-labeled oligo nucleotides were commercially available (table 2.14)
and incorporated into the ‘147’ sequence by PCR.




Rev Cy5 5’-Cy5-ACAGGATGTATATATCTGACA CGTGCCTG-3’
In order to generate labeled ‘147’-Widom 601 nucleosome positioning DNA sequence, PCR
was performed in 96-well plate, in a reaction volume of 50µL per well. Each reaction con-
tained 1x Taq buffer (10 mM TRIS-HCl pH 8.8, 50 mM KCl, 0.8 % [v/v] NP-40), 240µM dNTPs,
0.6µM forward primer (Fwd BtnTg or Fwd template), 0.6µM reversed primer (Rev Cy5),
1.5 mM MgCl2, 10 ng DNA template and 5 U Taq polymerase. In order to check the quality of
PCR, 5µL of the raw PCR mix was analyzed by agarose gel electrophoresis (chapter 2.2.3).
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2.2.7 PEG precipitation of biotinylated and Cy5-labeled ‘147’ Widom 601 DNA
template
The PCR amplified, biotin- and Cy5-labeled ’147’ Widom 601 DNA sequence was pooled
and precipitated with polyethylene glycol (PEG 6000) [123] by adding a 2 x PEG solution (28 %
PEG 6000, 1M NaCl) to give final concentration 1 x. After 15 min incubation at 37◦C DNA
was precipitated by centrifugation at 40000 rcf, 4◦C for 15 min. The DNA pellet was washed
with 5 mL 80 % EtOH, air dried and resuspended in ddH2O. Quality control was performed
by analyzing 200, 400 and 800 ng of purified DNA on an agarose gel observing intensities of
EtBr and Cy5-fluorescence as described in chapter 2.2.3.
2.3 Protein biochemistry methods
2.3.1 Techniques for analyzing proteins
Determination of protein concentration
The concentration (c) of proteins was determined by measuring the absorbance (A) at 280 or
276 nm using NanoDrop ND 1000 (optical path length d = 0.1 cm, but internally corrected to
d = 1 cm). According to the law of Lambert and Beer (equation 2.1) the protein concentration
was calculated using extinction coefficients retrieved on the base of protein sequence by the
tool ProtParam [124].
A = εnm · c · d (2.1)
Table 2.16: Physical parameters of recombinant proteins
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Table 2.16 – continued from previous page




The purity of proteins was assessed by SDS-PAGE [125]. In general, 15 % SDS polyacry-
lamide gels were handcasted. Proteins were denatured in 1 x Lämmli buffer (62,5 mM Tris-
HCl pH 6.8, 2 % [w/v] SDS, 10 % [v/v] glycerol, 0.1 % [w/v] bromphenol blue) and boiled for
5 min at 95◦C in SDS running buffer (25 mM TRIS base, 192 mM glycine, 1 % [w/v] SDS) with
200 V for 50 min at RT. If not meant for western blot analysis, SDS-gels were stained with
coomassie solution (0.1 % [w/v] Coomassie brilliant blue R250, 10 % [v/v] acetic acid, 50 %
[v/v] methanol) for 5 min and destained using destaining buffer (10 % [v/v] acetic acid, 7.5 %
[v/v] methanol) [126].
Western blot analysis
For the analysis of proteins in low pmol amount or to visualize a specific protein, western
blot analysis was performed [127]. Samples and SDS-PAGE were prepared and executed as
described above. Proteins were transferred to nitrocellulose membrane (0.45µm) for 1 h
with 100 V in transfer buffer (25 mM TRIS base, 192 mM glycine, 0.1 % [w/v] SDS, 20 %
[v/v] methanol). To the membrane transferred proteins were stained with Ponceau solution
(5 % [v/v] acetic acid, 0.1 % [w/v] Ponceau S) for 5 min at RT and rinsed with ddH2O until
protein bands were visible. Further, membrane was blocked for 1 h at RT with 5 % [w/v] milk
powder in PBST (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3,
0.1 % [v/v] TWEEN20), primary antibody (dilution according table 2.6, 5 % milk, PBS, 0.01 %
NaN3) was incubated with the membrane over night at 4◦C, washed 3 x 5 min with PBST and
incubated for 1 h at RT with secondary antibody (1:5000 in PBST). The secondary antibody
was removed and the membrane washed 3 x 15 min with PBST. Membranes incubated with
secondary antibody conjugated to HRP were treated with ECL western blotting detection
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reagents, resulting chemiluminescence was detected using the ChemiDoc imager system.
In case of membranes were incubated with secondary antibody conjugated to Alexa488,
fluorescence of Alexa488 was detected upon excitation at 488 nm by the ChemiDoc imager
system.
2.3.2 Expression of recombinant proteins
Expression of core histones
Expression of histones was carried out as described by Luger et al. [128]. Briefly, 1.5 L
of 2xYT media supplemented with ampicillin (0.1µg/mL) was inoculated 1:100 with a pre-
culture grown in LB with ampicillin (100µg/L), chloramphenicol (34µg/L) over night (ON) at
37◦C. The final culture was grown until an OD600 of 0.4 -0.6 was reached, 0.3 mM IPTG was
added and proteins were expressed for 3 h at 37◦C. Cells were collected by centrifugation at
6200 rcf, 4◦C for 15 min and stored at -80◦C.
Expression of His6-CFP-HP1-fusion proteins
His6-eCFP-HP1β, His6-mCFP-HP1β and His6-Cerulean-HP1β were expressed in E. coli
BL21 Rosetta cells. For the pre-culture, a single colony was picked and grown in 40 mL
LB medium supplemented with ampicillin (100µg/L) and chloramphenicol (34µg/L) for 5 h at
37◦C and 130 rpm shaking. 1.5 L 2xYT medium supplemented with ampicillin (100µg/L) and
chloramphenicol (34µg/L) was inoculated 1:75 or 1:100 with the pre-culture and grown at
37◦C and 125 rpm shaking until an OD600 of 0.3-0.5 was reached. Expression was induced
with 0.3 mM IPTG ON at 18◦C. Cells were collected by centrifugation at 6200 rcf, at 4◦C for
15 min. Cells were either stored at -80◦C or expressed proteins were immediately purified.
Expression of His6-yGCN5 and His6-Aurora B
Expression of His6-tagged GCN5 from yeast and His6-tagged Aurora B was performed in
E. coli BL21 RIL cells. For the pre-culture, a single colony was picked and grown in 200 mL LB
medium supplemented with ampicillin (100µg/L) and chloramphenicol (34µg/L) ON at 37◦C
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and 130 rpm shaking. For expression, 1.5 L 2xYT supplemented with ampicillin (100µg/L)
was inoculated 1:100 with the pre-culture and grown at 37◦C, 125 rpm shaking to an OD600
of 0.3-0.5. Expression was induced with 0.3 mM IPTG at 30◦C for 3 h.
2.3.3 Purification of recombinant proteins
Purification of core histones
Cells were resuspended in 50 mL wash buffer (50 mM TRIS-HCl pH 7.5, 100 mM NaCl, 1 mM
EDTA, 2 mM DTT, 1 mM PMSF, 1 mM benzamidin). Resuspended cells were lysed using
the EmulsiFlex 5C. Insoluble inclusion bodies were collected by centrifugation at 23000 rcf
at 4◦C for 20 min. Inclusion bodies were washed three times by resuspending the inclusion
body pellet in 100-200 mL TW buffer (50 mM TRIS-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA,
2 mM DTT, 1% v/v Triton X-100) and centrifugation at 23000 rcf at 4◦C for 20 min. Triton X-
100 was removed by another two wash steps using 200 mL wash buffer. Inclusion bodies
were stored at -20◦C.
Histones were extracted form inclusion bodies by adding 2 mL DMSO and incubation at RT
for 30 min. In a first round, histones were solubilized with 30 mL of unfolding buffer (20 mM
TRIS-HCl pH 7.5, 7 M guanidine hydrochloride, 10 mM DTT) for 1 h at RT. Then, separated
from insoluble matter by centrifugation at 23000 rcf, 4◦C for 20 min. In a second round, ex-
traction of histones was performed by incubating the remaining pellet with 10 mL unfolding
buffer for 30 min and centrifugation. Supernatants were pooled and dialyzed against SAU200
(20 mM sodium acetate pH 5.2, 7 M urea freshly deionized, 1 mM EDTA, 200 mM NaCl, 2 mM
DTT). Histones were purified from DNA by loading them onto in SAU200 pre-equilibrated
Q-Sepharose XK26/20 and SP-Sepharose XK26/20 column combination connected in se-
ries. When the input had reached the SP-Sepharose column, the Q-Sepharose column was
disconnected and the SP-Sepharose column was washed with SAU200 until baseline of pro-
tein detection (absorbance at 280 nm or 276 nm) was reached. Histones were eluted with
SAU600 (20 mM sodium acetate pH 5.2, 7 M urea freshly deionized, 1 mM EDTA, 600 mM
NaCl, 2 mM DTT) from the SP-Sepharose column using a step gradient 30 % SAU600 for
1 CV followed by a linear gradient from 30-100 % SAU600 over 1 CV. Fractions were ana-
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lyzed by SDS-PAGE (chapter 2.3.1). Histone containing fractions were pooled and dialyzed
against H2O with 2 mM DTT and lyophilized. Histones were stored at -80◦C.
Purification of His6-CFP-HP1-fusion proteins
For purification, a cell pellet corresponding to 1.5 L culture was resuspended in lysis buffer
(50 mM NaPi pH 7.9, 300 mM NaCl, 10 mM imidazole, protease inhibitor EDTA free) and
lysed by three passages through the EmulsiFlex 5C homogenizer. Lysate was cleared by
centrifugation at 30000 rcf, 4◦C for 45min. Affinity chromatography was performed using Ni-
NTA agarose beads pre-equilibrated in lysis buffer and packed in a column for gravity flow.
After the lysate passed through, resin was washed with 20 mL of lysis buffer followed by
250 mL of wash buffer (50 mM NaPi pH 7.9, 1 M NaCl, 30 mM imidazole). The CFP proteins
were eluted in 4 mL elution buffer (50 mM NaPi pH 7.9, 300 mM NaCl, 300 mM imidazole) and
immediately dialyzed against 20 mM N(EtOH)3 7.5, 300 mM NaCl, 0.1 mM EDTA. Proteins
were concentrated to 5-10 mg/mL with Amicon centrifugal filter with a MWCO of 30 kDa and
used immediately for the CFP-HP1 binding assay with nucleosome core particle immobilized
in 96-well plate or stored at 4◦C.
Purification of His6-yGCN5 and His6-Aurora B
For purification of His6-yGCN5 and His6-Aurora B, cells were resuspended in lysis buffer
(50 mM NaPi pH 8.0, 10 mM imidazole, 300 mM NaCl, 2 mM β-mercaptoethanol) and lysed
by three passages through the EmulsiFlex C5 homogenizer. Lysate was cleared by cen-
trifugation at 30000 rcf at 4◦C for 45 min. 50 mL lysate was incubated with in lysis buffer
pre-equilibrated Ni-NTA agarose slurry for 1 h at 4◦C. Ni-NTA resin was allowed to settle in
a column and washed with 20 mL lysis buffer and 100 mL wash buffer (50 mM NaPi pH 8.0,
10 mM imidazole, 500 mM NaCl, 2 mM β-mercaptoethanol). His6-tagged protein was eluted
with 50 mM NaPi pH 8.0, 300 mM NaCl, 5 % glycerol, 2 mM β-mercaptoethanol, 300 mM imi-
dazole. Eluate was concentrated and diluted using 3x GCN5 buffer (30 mM TRIS-HCl pH 8.0,
30 % glycerol 0.3 mM EDTA, 15 mM β-mercaptoethanol) to 40µM, aliquoted, then they were
flash frozen and stored at -80◦C.
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2.3.4 Assembly of histone octamers
According to the established protocol [129], lyophilized histones were dissolved in unfolding
buffer (20 mM TRIS-HCl pH 7.5, 7 M guanidine hydrochloride, 10 mM DTT) to 2 mg/mL. Con-
centration of histones were determined by measuring the absorbance at 276 nm using extinc-
tion coefficient and molecular weight listed in table 2.16. Histones were combined equimolar
and diluted using unfolding buffer to a final protein concentration of 1 mg/mL. Histone oc-
tamers were dialyzed against RB high (10 mM TRIS-HCl pH 7.5, 2 M NaCl, 1 mM EDTA,
2 mM DTT). Any precipitate was removed by centrifugation at 3220 rcf, 4◦C for 10 min. In
preparation for size exclusion chromatography, histone octamers were concentrated using
Amicon Ultra-15 centrifugal filter with MWCO 30 kDa. Precipitate was removed by centrifu-
gation at 10000 rcf, at 4◦C for 10 min. Histone octamers were purified using either Superdex
200 10/300 GL or HiLoad Superdex 200 16/600 PG depending on the input volume. Elution
fractions were analyzed by SDS PAGE (chapter 2.3.1). Those fractions containing histone
octamer showing an equal amount of all four histones were pooled and stored in 50 % glyc-
erol at -20◦C. IntC-H2A containing octamers were directly used for nucleosome core particle
reconstitution.
2.3.5 Reconstitution of ligation-ready nucleosome core particles
For the reconstitution of NCP the standard protocol was followed [129]. In general, the con-
centration of histone octamer was determined by measuring the absorbance at 276 nm and
assessing the concentration, using an extinction coefficient calculated by summation of the
single extinction coefficients of each histone (table 2.16) as it has been suggested by Dyer et
al. [129]. For NCP reconstitution, histone octamers and DNA were set up in RB high (10 mM
TRIS-HCl pH 7.5, 2 M NaCl, 1 mM EDTA, 2 mM DTT). For small scale titration series, 0.9-
1.2 eq. octamer was mixed with 1.0 eq. DNA in RB high (small scale: 1.0 eq. = 140 pmol,
3-5µM, large scale: 1.0 eq.>500 pmol, 3µM). Prior to the addition of histone octamer, the
DNA was adjusted with 5 M NaCl to 2 M NaCl. Using a peristaltic pump a gradient to RB low
(10 mM TRIS-HCl pH 7.5, 25 mM NaCl, 1 mM EDTA, 2 mM DTT) was applied by dialysis at
4◦C over 24 h (small scale) or 36 h (large scale). Quality of NCP reconstitution was analyzed
by agarose gel electrophoresis (chapter 2.2.3).
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2.3.6 Immobilization of nucleosome core particles in 96-well plate
For eCFP-HP1 binding-and enzymatic activity assay on immobilized H3-NCP library in 96-
well format, ligation-ready H3∆-NCP were immobilized on 96-well black, STA coated 96-well
plates (BA-plates, 100µL STA coating volume, high binding capacity: 125 pmol/well) or 96-
well, white Flash plates (200µL STA coating volume, binding capacity ∼40 pmol/well). STA
coated 96-well plates were prepared for NCP immobilization by washing 3x 200µL with RB
low (10 mM TRIS-HCl pH 7.5, 25 mM NaCl, 1 mM EDTA, 2 mM DTT). NCP were immobilized
by adding 50µL per well (BA-plates) or 100µL (Flash plates) of H3∆-NCP (4µM) and incu-
bation for 20 h at RT. Unbound NCPs were removed and stored at 4◦ and reused for NCP
coating of more plates. Wells containing immobilized NCP were washed 3x 200µL BA-buffer
(20 mM N(EtOH)3 pH 7.5, 300 mM NaCl, 5 % [v/v] glycerol, 0.1 mM EDTA ) and stored in
200µL BA-buffer at 4◦C.
2.3.7 Ligation of histone H3 tail to H3∆-NCP using Sortase A
Synthesis of histone tails carrying PTMs listed in table 2.17 and their Sortase A mediated
ligation to immobilized H3-∆-NCP in 96-well BA- and Flash plate was performed by Diego
Aparicio Pelaz (Eberhard Karls Universität Tübingen, Tübingen).
Table 2.17: Library of histone H3 modifications used for binding and activity assays and H2A
modifications
# (k) Histone H3 modifications # (k) Histone H3 modifications
1 H3K4me2 19 H3K9me2K27me2
2 H3K4me2 K9me2 20 H3K9me2S28ph
3 H3K4me2S10ph 21 H3K9me2S10phK27me2
4 H3K4me2K27me2 22 H3K9me2S10phS28ph
5 H3K4me2S28ph 23 H3K9me2K27me2S28ph
6 H3K4me2K9me2S10ph 24 H3K9me2S10phK27me2S28ph
7 H3K4me2K9me2K27me2 25 H3S10ph
8 H3K4me2K9me2S28ph 26 H3S10phK27me2
9 H3K4me2S10phK27me2 27 H3S10phS28ph
10 H3K4me2S10phS28ph 28 H3S10phK27me2S28ph
11 H3K4me2K27me2S28ph 29 H3K27me2
12 H3K4me2K9me2S10phK27me2 30 H3K27me2S28ph
13 H3K4me2K9me2S10phS28ph 31 H3S28ph
14 H3K4me2K9me2K27me2S28ph 32 unmodified
15 H3K4me2S10phK27me2S28ph 33 H3∆1-32
16 H3K4me2K9me2S10phK27me2S28ph 34 H3K4ac
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Table 2.17 – continued from previous page
# (k) Histone H3 modifications # (k) Histone H3 modifications
17 H3K9me2 35 H3K27ac
18 H3K9me2S10ph 36 H3K9ac
# (k) Histone H2A modifications # (k) Histone H2A modifications
A H2AK5ac E H2AR3me2a
B H2AK5acR3me2a F H2AS1ph
C H2AS1phK5ac G H2AS1phR3me2a
D H2Aunmodified H H2AS1phR3me2aK5ac
2.3.8 Ligation of histone H2A tail to IntC-H2A-NCP using protein
trans-splicing
Ligation conditions were set up on the base of Ludwig et al. [97]. Accordingly, IntC-H2A NCP
were dialyzed against AB25 (50 mM TRIS-HCl pH 7.0, 25 mM NaCl, 1 mM EDTA, 2 mM DTT,
10 % glycerol). 100µL IntC-H2A-NCP (181 pmol, stock 1.8µM) were adjusted to 300 mM
NaCl (5.83µL, stock 5 M) and 10 eq. of unmodified IntC-H2A1−18 (5.42µL, 1.81 nmol, stock
334µM) in a final volume of 111.24µL and incubated for 4 h at 25◦C. Further optimization was
done by Diego Aparicio Pelaz (Eberhard Karls Universität Tübingen) with the final conditions:
protein trans-splicing was performed in solution in total volume of 650µL per modification with
325µL IntC-H2A-NCP (2.74 nmol, stock 8.45µM) and 58.5µL H2A-peptide (58.5 nmol, stock
1 mM) incubating for 72 h at RT.
2.4 Biochemical assays
2.4.1 Peptide pull-down – standard protocol
In order to check whether CFP-derivatives HP1 conjugates distinguish between histone H3
tail unmodified (pH3um) and methylated on lysine 9 (pH3K9me3), peptide pull-down was per-
formed. First, 40µL of streptavidin coated beads were equilibrated in PBS buffer (137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3) by washing 3 x 80µL PBS.
The peptide of interest was bound to the beads by incubation of 10µg peptide in 80µL
total volume PBS and rotation for 3 h at RT. Beads were washed 3 x 80µL PBS. 5µg His6-
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CFP-HP1 fusion protein (95 pmol) in 500µL pull-down buffer PD-300 (20 mM HEPES pH 7.9,
300 mM NaCl, 0.2 % Triton X-100, 20 % glycerol) was incubated for 4 h or ON with the immo-
bilized peptides on the beads, rotating at 4◦C. Beads were washed 6 x 500µL for 5 min with
PD-300. For analysis, peptide bound proteins were eluted by adding 20µL of 2 x SDS buffer
and boiling for 5 min at 95◦C. Proteins bound to the according peptide was detected by stan-
dard SDS-PAGE and western blot analysis using antibody against GFP that also recognizes
CFP derivatives.
2.4.2 Peptide pull-down – optimized protocol
Peptides were immobilized on streptavidin coated magnetic beads as described above (chap-
ter 2.4.1). 5µg His6-CFP-HP1 fusion protein (95 pmol) in 500µL pull-down buffer PDopt-300
(20 mM N(EtOH)3 pH 7.5, 300 mM NaCl, 0.1 % [v/v] Triton X-100, 0,1 mM EDTA, 15 % [v/v]
glycerol, 1 mg/mL BSA) was incubated for time frames as indicated (1.5, 4 h or ON) with
peptide-bound beads, rotating at 4◦C. Beads were washed 6 x 500µL with PDopt-300 (-BSA)
for 5 min. For analysis, peptide bound proteins were eluted by adding 20µL of 2 x SDS buffer
and boiling for 5 min at 95◦C. Proteins bound to the according peptides were detected by
standard SDS-PAGE and western blot analysis using antibody against GFP that also recog-
nizes CFP derivatives.
2.4.3 Binding assay – 96-well format
Streptavidin coated 96-well plates with a coating volume of 100µL and high binding capacity
of 125 pmol/well were used for all fluorescence based binding assays. They were coated with
50µL of ligation-ready NCPs as described in chapter 2.3.6.
Proof of principle experiment
In order to check whether the principle experimental design was functional, binding of eCFP-
labeled HP1 to immobilized and H3 modified NCP was observed by detection of in-well
fluorescence of eCFP-HP1. Herefore, eCFP-HP1 protein was thawed and dialyzed into
10 mM N(EtOH)3 pH 7.5, 150 mM NaCl. Subsequently diluted 1:1 with binding buffer (10 mM
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N(EtOH)3, 150 mM NaCl, 0.2 % [v/v] Triton X-100, 10 % [v/v] glycerol, 0.2 mM EDTA) to a
final concentration of 10µM. Wells were washed 3 x 100µL binding buffer (10 mM N(EtOH)3,
150 mM NaCl, 0.1 % [v/v] Triton X-100, 5 % [v/v] glycerol, 0.1 mM EDTA). 50µL of eCFP-HP1
(10µM) was added into each well and incubated ON at 4◦C, rocking. Unbound proteins were
removed and wells were washed 4 x with 50µL binding buffer except for the third washing
step (100µL). Measurement of eCFP and Cy5-fluorescence took place after each washing
step with the settings listed in table 2.18.
Table 2.18: Measurement parameters using GENios plate reader
Parameter CFP proteins Cy5
Excitation wavelength 450 nm 612 nm
Emission wavelength 520 nm 670 nm
Gain (optimal) 66 66
Integration time 40µs 40µs
Conditions for optimization of incubation time and wash steps
In order to check the impact of incubation time and wash steps on the signal intensities,
17.5µM eCFP-HP1 in BB-H (20 mM HEPES, 150 mM NaCl, 0.1 % [v/v] Triton X-100, 5 %
[v/v] glycerol, 0.1 mM EDTA) was incubated in a total volume of 50µL/well with immobi-
lized H3um-NCP and H3K9me2-NCP for 5, 30, 60 and 180 min at 4◦C, rocking. After in-
dicated incubation time, wells were washed 3 x 100µL/well for 5 min with WB-H (20 mM
HEPES, 300 mM NaCl, 0.1 % [v/v] Triton X-100, 5 % [v/v] glycerol, 0.1 mM EDTA) at 4◦C,
rocking. Subsequently, 50µL PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4, pH 7.3) were added for the first fluorescence measurement after an incubation time
of 180 min (measurement #1). The plate was incubated over night at 4◦C and reread (mea-
surement #2). 50µL/well PBS were added and fluorescence measurement was performed
(measurement #3). Subsequently, wells were washed 3 x 100µL/well WB-H for 5 min at 4◦C
and measured in 50µL/PBS (measurement #4). This last wash cycle was repeated once
more and fluorescence data were obtained (measurement #5). Fluorescence was measured
with the settings listed in table 2.19. The plate reader was changed because the infinite
M1000Pro selects excitation wavelength by an monochromator and not by filters as it is in




Table 2.19: 1st settings using infinite M1000Pro plate reader
Parameter CFP proteins Cy5
Excitation wavelength 434 nm 649 nm
Emission wavelength 477 nm 670 nm
Excitation bandwidth 5 nm 5 nm
Emission bandwidth 5 nm 5 nm
Gain optimal (100 %) variable variable
Number of flashes 50 50
Integration time 20µs 20µs
Z-position (standard) 2000µm 20000µm
Conditions for 1st eCFP-HP1 binding assay on H3-NCP library
The first experiment on one whole library (modification #1-33, table 2.17) was performed with
eCFP-HP1 from a stock of 70µM adjusted with 2 x binding buffer (2 x BB-H: 40 mM HEPES
pH 7.5, 300 mM NaCl, 0.2 % [v/v] Triton X-100, 10 % [v/v] glycerol and 0.2 mM EDTA) to a
final concentration of 17.5µM eCFP-HP1 in 1 x BB-H. Proteins were incubated over night at
4◦C, rocking. eCFP-HP1 load per well was measured, unbound proteins were removed and
wells were washed 3 x 200µL WB-H300 (10 mM HEPES pH 7.5, 300 mM NaCl, 0.1 % [v/v]
Triton X-100, 5 % [v/v] glycerol and 0.1 mM EDTA). Bound eCFP-HP1 and immobilized NCP
were detected in WB-H300 using the settings listed in table 2.19.
Conditions for 2nd eCFP-HP1 binding assay on three H3-NCP libraries
In contrast to the afore mentioned HP1-binding assay, assay conditions were altered in sev-
eral points: H3-NCP libraries were pre-blocked with BSA and DNA, eCFP-HP1 incubation
time with the library was reduced and fluorescence was detected in PBS. In detail, three
libraries were washed 3 x 100µL BB-H (10 mM HEPES pH 7.5, 150 mM NaCl, 0.1 % [v/v] Tri-
ton X-100, 5 % [v/v] glycerol and 0.1 mM EDTA) and blocked with blocking buffer (1.0 mg/mL
BSA, 0.1 mg/mL ssDNA, 1 x BB-H) for at least 15 min at 4◦C, rocking. Pre-blocked libraries
were incubated with 50µL eCFP-HP1 (30µM) protein adjusted with 2 x BB-H to final 30µM
in 1 x BB-H for 90 min at 4◦C, rocking. Unbound protein was removed and wells were washed
3 x 100µL WB-H300 (10 mM HEPES pH 7.5, 300 mM NaCl, 0.1 % [v/v] Triton X-100, 5 % [v/v]
glycerol and 0.1 mM EDTA) for 5 min at 4◦C. Libraries were measured in 1 x PBS (137 mM
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NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3) using the settings listed in
table 2.20.
Release of bound material into solution using restriction enzyme EcoRI
In order to see whether the release of NCP into solution would have an impact on the signal
intensity of Cy5 and eCFP, one library was washed 3 x 100µL BB-H (10 mM HEPES pH 7.5,
150 mM NaCl, 0.1 % [v/v] Triton X-100, 5 % [v/v] glycerol and 0.1 mM EDTA) and blocked
with blocking buffer (1.0 mg/mL BSA, 0.1 mg/mL ssDNA, 1 x BB-H) for at least 15 min at 4◦C,
rocking. The pre-blocked library was incubated with 60µM eCFP-HP1 and washed 3 x 100µL
with WB-H100 (10 mM HEPES pH 7.5, 100 mM NaCl, 0.1 % Triton X-100, 5 % [v/v] glycerol
and 0.1 mM EDTA). The libraries were measured in 60µL EcoRI buffer (50 mM TRIS-HCl
pH 7.5, 10 mM MgCl2, 50 mM NaCl) then 10µL per well of EcoRI (1 U/µL in EcoRI buffer)
was added and incubated at 37°C. After 5 min the first measurement was taken and incuba-
tion at 37◦C was continued in the plate reader. Every 5 min for 1 h, fluorescence of eCFP
and Cy5 was measured. An 1:1 dilution series of eCFP and Cy5 in EcoRI buffer for signal
calibration was placed on the plate ranging from 500 pmol/well to 4 pmol/well for eCFP and
100 pmol/well to 1 pmol/well for Cy5 fluorophore.
Final eCFP-HP1 binding assay conditions
Optimized eCFP-HP1 binding assay conditions were developed and used for eCFP-, mCFP-
and Cerulean-HP1 binding. In detail, on BA-plates immobilized H3 modified-NCP were
washed 3x200µL binding buffer PDopt 300 (20 mM N(EtOH)3 pH 7.5, 300 mM NaCl, 0.1 [v/v]
Triton X-100, 15 % [v/v] glycerol, 0.1 mM EDTA). The wells and immobilized NCP were pre-
blocked for 30 min at 4◦C with 100µL blocking buffer (1.0 mg/mL BSA, 0.1 mg/mL ssDNA,
1 x PDopt 300). NCP-coated wells were loaded with 50µL/well binding mix (33µM CFP-
HP1 protein, 1.0 mg/mL BSA, 0.1 mg/mL ssDNA in 1 x PDopt 300) and incubated for 90 min
at 4◦C, slightly shaking. After incubation, the binding mix was removed, wells were briefly
washed with 200µL wash buffer (20 mM N(EtOH)3 pH 7.5, 150 mM NaCl, 0.1 [v/v] Triton
X-100, 15 % [v/v] glycerol, 0.1 mM EDTA) and placed in 50µL measuring buffer (20 mM
N(EtOH)3 pH 7.5, 150 mM NaCl, 15 % [v/v] glycerol, 0.1 mM EDTA). An 1:1 dilution series
in measuring buffer for CFP and Cy5 fluorophores was prepared from 50.0 to 0.39 pmol Cy5
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and 80.0 to 0.62 pmol CFP-HP1 and placed into the plate. The plates were let to adapt to
measuring temperature (20◦C) and measured in triplicates with 1 min interval between one
reading of the plate using the plate reader settings shown in table 2.20.
Table 2.20: 2nd settings using infinite M1000Pro plate reader
Parameter CFP proteins Cy5
Excitation wavelength 434 nm 649 nm
Emission wavelength 477 nm 670 nm
Excitation bandwidth 5 nm 5 nm
Emission bandwidth 5 nm 5 nm
Gain 107 107
Number of flashes 50 50
Integration time 20µs 20µs
Z-position (Manual) 17687µm 17687µm
2.4.4 Data analysis for plates with reference wells for fluorophores
Conversion of raw fluorescence data [a.u.] into [pmol]
Well Ak with the modification k = 1 to 36 (see table 2.17, page 37) was sequentially measured
for eCFP-HP1 and Cy5-NCP fluorescence. The fluorescence of eCFP-HP1 was measured in
a.u. and the whole plate was measured three times (n=1, ..., 3) with an interval of one minute
between each plate measurement. Fluorescence data of the dilution series of eCFP or Cy5
reference wells were plotted against the concentration. A linear regression was performed
(R2 > 0.95) resulting in a linear calibration curve with cn = f(xn) = axn + b for eCFP-HP1
and for Cy5-NCP dn = f(yn) = ayn + b for the transformation of the units [a.u.] into [pmol].
Error propagation of independent fluorescence detection of eCFP and Cy5
Before starting with the data analysis for plates containing reference wells for eCFP and
Cy5-fluorescence, the error resulting from the independent measurement of Cy5 and eCFP
fluorescence and its propagation to the final ratio of eCFP-HP1/Cy5-NCP was determined.
To this end, the standard error s̄ was determined on base of three technical repeats for each
modification. For eCFP, s̄x̄ = σx̄√n and Cy5, s̄ȳ =
σȳ√
n
with σ being the standard deviation
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of the technical replicates n in the eCFP (x) or Cy5 (y) channel. This led to the following
description of the measurement in each well for each modification k: Xk = x̄k ± s̄x̄ with the
mean x̄ = 1n ·
∑n
i=1 xki. The same was applied for Cy5: Yk = ȳk ± s̄ȳ with ȳ = 1n ·
∑n
i=1 yki.
The recruitment of eCFP-HP1 to NCP depended on how many NCP molecules were present
in the well: Zk = z̄k ± ∆zk with z̄k = x̄kȳk and ∆zk =










∆zk or relative errors
∣∣∣∆zkz̄k ∣∣∣ were propagated using the Gaussian relation for propagating
the standard error from both sources of uncertainty: the error introduced by the eCFP and
the Cy5 measurement [130]. From the experiment described in figure 3.15, the mean of the
relative error over one whole library was for replicate #1, #2, and #3 3.24 %, 3.95 % and
1.76 %, respectively. As the technical error was < 5 % over the whole library, the contribution
of the technical error to the overall uncertainty was minor. Therefore it was neglected in
further considerations.
Data analysis and normalization
Raw fluorescence data was transformed from [a.u.] into [pmol] as described above. The
eCFP signal was normalized to the Cy5-NCP fluorescence signal for each well. The eCFP-
HP1 recruitment to Cy5-NCP with the modification k was plotted as the mean z̄lk with ± the












) for experiments performed in repli-
cates l > 2.
For direct comparison of data sets from different plates, data of each modification k with




2.4.5 Data analysis for plates without reference wells for fluorophores
Early measurements were taken without reference wells for fluorescence calibration on the
plate with automatically or manually entered gain settings. For data processing, background
values (buffer only, N) were subtracted from signal and divided by the gain used by the
plate reader. This was performed for eCFP-HP1 Xk = Sk−NGain and Cy5-NCP Yk =
Sk−N
Gain .
Recruitment of HP1 per NCP was calculated with Zk = xkyk and only the error based on the
standard deviation between l wells of the same modification was plotted as error bar.
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2.4.6 Activity assay – 96-well format
For all radioactivity based activity assays, STA coated Flash plates were used with a STA-
coating volume of 200µL, biotin binding capacity ∼40 pmol/well. Flash plates were coated
as described in chapter 2.3.6 with 100µL NCPs if not stated otherwise.
HAT assay
For optimization experiments 50-200µL/well NCPs containing WT histones were immobilized
on STA-coated 96-well Flash plate and washed 3 x with 200µL HAT assay buffer (50 mM
TRIS-HCl pH 8.0, 50 mM NaCl, 10 % [v/v] glycerol, 0.1 mM EDTA, 1 mM DTT and 10 mM
n-butyrate). 50-200µL/well reaction mix (2.4µM yGCN5, 0.08µCi/well [acetyl-1-14C]-acetyl
coenzyme A in HAT assay buffer) was added to the well, spun for 1 min, 3220 rcf at 4◦C and
incubated for 2 h at 30◦C, slightly shaking (hybridization oven). After removal of the reaction
mix, wells were washed 3 x 200µL HAT wash buffer (50 mM TRIS-HCl pH 8.0, 300 mM NaCl,
10 % [v/v] glycerol, 1 % [w/v] CHAPS 0.1 mM EDTA) and incorporated radioisotopes were
detected in 100µL HAT wash buffer for 120 sec/well using the standard settings for 14C-
detection (low limit 50 and high limit 900, Chameleon V plate reader).
For the initial experiment shown in figure 3.20 (B), 200µL reaction mix (1.2µM GCN5,
0.02µCi 14C-AcCoA in 1 x HAT buffer) were incubated for 45 min at 30◦C and washed 4 x 700µL
HAT wash buffer, last wash over night.
Final conditions: H3∆-NCPs were immobilized with 100µL coating volume on 96-well
plates and two libraries of histone H3 modifications described in table 2.17 were ligated in a
random pattern on the plate using Sortase A (ligation was performed by Diego Aparicio Pelaz,
Eberhard Karls Universität Tübingen, Tübingen). The HAT assay with GCN5 was performed
in 100µL reaction mix per well (2.4µM yGCN5, 0.08µCi/well [acetyl-1-14C]-acetyl coenzyme
A in HAT buffer), washed with 3 x 200µL HAT wash buffer (50 mM TRIS-HCl pH 8.0, 300 mM
NaCl, 10 % [v/v] glycerol, 1 % [w/v] CHAPS, 0.1 mM EDTA) and counted in 100µL HAT wash
buffer for 120 sec/ well. Fluorescence of Cy5-NCP was measured with the same device using
a manual gain of 20.
45
2 MATERIAL AND METHODS
Kinase assay
Similar to the HAT assay, the kinase assay with Aurora B was performed using described
buffer conditions [131]. Wells were washed 3 x 200µL with kinase buffer (5 mM MOPS pH 7.2,
1 mM EGTA, 0.4 mM EDTA, 5 mM MgCl2). 100µL of the reaction mix (40 nM Aurora B, 20 nM
[γ 32P] ATP, 40 nM ATP, 2.5 mM β-glycerophosphat, 50µM DTT) were added to each well and
incubated for indicated time points (maximal 120 min) at 30◦C, slightly shaking (hybridization
oven). After removal of the reaction mix, wells were washed with 200µL wash buffer (5 mM
MOPS pH 7.2, 1 mM EGTA, 0.4 mM EDTA, 1 % CHAPS, 300 mM NaCl). Wells were counted
for 3 x 10 sec in 100µL kinase buffer using the plate reader Chameleon V and the standard
settings for 32P (low limit: 10 and high limit 1023). Fluorescence of Cy5-NCP was measured
with the same device using a manual gain of 20.
Data analysis of radioactive HAT-, and kinase assays
Cy5-NCP fluorescence was converted from [a.u.] to [pmol] as described in chapter 2.4.4 by
means of a dilution series of Cy5 calibration wells within the plate. Fluorescence intensity
were plotted against the concentration and a linear regression was performed. Radioactivity
was measured for 120 seconds (32P for 3 x 10 sec) in CPM and corrected for the background,
that was empty wells incubated with reaction mix and treated exactly as the sample wells
were treated. The division of background corrected counts by Cy5-NCP coverage in [pmol]
resulted in an activity signal per NCP [CPM/pmol] for each well and modification. Error
bars were plotted as the standard deviation of at least 3 different wells containing the same
modification.
Outliers were identified by determining the inter quartile range (IQR: Q3 - Q1) of the whole
data set (with replicates l > 4) falling either below the inner lower (IQR - 1.5·Q1) or above
the inner upper limit (IQR - 1.5·Q3). In addition, values were not taken for analysis, when no
NCP signal was obtained for a specific modification.
Significance was tested by using a two sample, heteroscedastic, two sided t-test.
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3.1 Building block for reconstitution of ligation-ready NCPs
For the development of immobilized ligation-ready nucleosomes, we used recombinant Xeno-
pus laevis histones. In general, histones are quite conserved among species. Histones
from X. laevis share high sequence identity with human histones (H2A: 94 %, H2B: 95 %
H3: 99 %, H4: 100%) and are well characterized [3;128]. For the stable and uniform assem-
bly of chromatin, the artificial ’601 Widom’ positioning DNA sequence was used [122;132]. A
minimum of 147 base pairs of the ‘601 Widom’ sequence is needed to wrap around the hi-
stone octamer to assemble the nucleosome core particle NCP (from now on referred to as
‘147’-positioning sequence).
3.1.1 Biotin- and Cy5-labeled ’147’-DNA template
For the immobilization of NCPs in 96-well plates, we wanted a site-directed, irreversible link-
age between the plate and NCPs under mild reaction conditions. Such a linkage is provided
by the affine interaction between streptavidin and biotin [133]. Since streptavidin coated plates
were commercially available, biotin was introduced to the 5’ end of the ‘147’-positioning se-
quence using a biotinylated primer. For the purpose of normalization and determination of
NCP coating within each well, the 3’ end of the ‘147’-positioning sequence was labeled with
a Cy5 fluorophore using a Cy5-labeled primer. To allow for flexible usage of the generated
modified NCP, e.g. for analytics of the NCP complex outside the 96-well-plate, three differ-
ent DNA recognition sequences for restriction enzymes (HindIII, EcoRI and EcoRV) were
inserted between the biotin tag and the ‘147’-positioning sequence (see figure 3.1 (A)). In
the following, the whole modified construct will be referred to as ‘147’-DNA, since this is
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the length of the positioning sequence. PCR amplified ‘147’-DNA constructs were purified
by PEG precipitation. This way, surplus primer and polymerase were efficiently removed in
one purification step. The efficiency of the PCR reaction was observed by detection of Cy5-
fluorescence of the unprocessed PCR product revealing ‘147’ product and surplus primer





















































Figure 3.1: Biotin- and Cy5-labeled ’147’-DNA
(A) Schematic representation of ’147’-DNA 5’ labeled with biotin, followed by
three restriction sites (RSs) for restriction enzymes HindIII, EcoRI and EcoRV
and 3’ labeled with Cy5 dye. (B) Agarose gel of purified, EtBr stained ’147’-DNA,
observed under UV shows the quality of the PCR reaction. Detection of Cy5-
fluorescence revealed the efficiency of PCR reaction by the amount of unused
primer during PCR reaction.
3.1.2 Assembly of ligation-ready histone octamers
For the introduction of post-translational modified histone tails to the corresponding histone
(H2A or H3), we wanted to perform histone type-specific ligation in the context of NCP. There-
fore, histones were modified in a way that allows for site-specific ligation. To this end, histone
H2A was modified for ligation using protein trans-splicing. Whereas, H3 was modified to
allow for Sortase A mediated ligation. This meant generating an IntC-SIE-H2A∆1-18 and
a truncated H3∆1-32 fusion construct for recombinant expression in bacteria. The native,
intein flanking amino acid sequence ’SIE’ between IntC and H2A enhances the efficiency of
ligation [96]. Such recombinant modified and wild type histones were assembled to histone
octamers [129]. In agreement with the literature [129], we observed three major protein fractions
for a typical purification by size exclusion chromatography of assembled octamers. At first,
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Figure 3.2: Quality of the assembly of mono and double modified histone octamer
Elution profile of size exclusion chromatography using HiLoad Superdex200
16/60 PG column for the purification of in vitro assembled histone octamer
H3∆ (A), IntC-H2A (B) and double modified IntC-H2A/H3∆ (C). Analysis of




close to the void volume of the size exclusion column eluted aggregated material. Secondly
and thirdly eluted the octamer and dimer fractions, which had a good peak separation. The
assembly of mono-modified histone octamer with H3∆1-32 displayed the best ratio between
octamer, aggregate and dimer fraction (figure 3.2 (A)). Whereas, histone octamers containing
IntC-H2A assembled less efficient (figure 3.2 (B)). During the assembly of octamers contain-
ing both IntC-H2A and H3∆1-32, a significant amount formed aggregates (figure 3.2 (C)).
Nevertheless, octamer fractions contained equal amounts of all four histone types assessed
by CBB stained polyacrylamide gels (figure 3.2) were used for nucleosome reconstitution.
3.1.3 Reconstitution of ligation-ready NCPs
NCP were reconstituted from histone octamer and ‘147’-DNA by dialyzing both components
together from high salt to low salt conditions by applying a salt gradient over 36 h as de-
scribed by Luger et al. Before each large-scale reconstitution (1.0 eq>500 pmol), in a small-
scale set up (1.0 eq≈150 pmol) ratios were tested between DNA and octamer in a range
of 0.9-1.2 eq octamer to 1.0 eq ‘147’-DNA. The NCP reconstitution was analyzed by native
agarose gel electrophoresis. It showed the efficiency of NCP formation by the amount of free
DNA, which migrated faster than the NCP. For the reconstitution of H3∆-NCP, typically an oc-
tamer:DNA ratio of 1.0 -1.1 was sufficient for consumption of all free DNA. In contrast, during
the reconstitution of NCPs with IntC-H2A containing octamers, aggregation of the complex
was observed concomitantly with the consumption of free DNA. Thus, the octamer:DNA ratio
was chosen to keep precipitation at a moderate level, resulting in small amount of free DNA
after the reconstitution of NCPs (figure 3.3). IntC-H2A containing NCPs were transferred into
the PtS-ligation buffer containing low salt for further immobilization. Whereas, H3∆-NCPs
were stable in reconstitution buffer.
3.2 Ligation in context of NCP
We wished to ligate post-translational modified H2A and H3 histone tails synthesized by
SPPS to the corresponding histone type in the context of the nucleosome core particle. For
this, SrtA mediated ligation was chosen for addressing histone H3 and PtS for histone H2A.
50








































































Figure 3.3: Analysis of reconstituted single and double modified NCPs
(A) Schematic representation of reconstituted NCP with corresponding modified
histones. (B) EtBr stained native agarose gel of small-scale titration series to
determine the ratio between octamer and ‘147’-DNA for large-scale reconstitu-
tion. (C) Analysis of large-scale reconstitution of mono (H3∆) and double (IntC-
H2A/H3∆) modified NCPs by EtBr stained native agarose gel electrophoresis.
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3.2.1 Histone H3: Sortase A mediated ligation
Sortase A mediated ligation was chosen to target histone H3, because the recognition se-
quence of SrtA is present in the native sequence of H3. However, the very promising SrtA
mutant F40 accepting the amino acid sequence APXTG as substrate which is truly native in
H3 (H329-32: APAT) was not efficient enough to mediate ligation between histone tail and H3
in the context of NCP for all histone tail modifications. Nevertheless, the original SrtA recog-
nizing LPXTG motif was more efficient for H3∆-NCP ligation with modified H3-tail-peptides
resulting in H3A29L ligation product. To this end, 32 H3 tail peptides carrying di-methylation
on H3K4, H3K9, H3K27 and phosphorylation on H3S10 and H3S28 were synthesized in all
combinations ranging from single-modified to pentupel-modified H3 tail peptides. Ligation
was performed by SrtA with immobilized H3∆-NCP in a 96-well plate. This way, each well
contained NCPs carrying a specific type of histone tail modifications. In figure 3.4 the con-
version of H3∆-NCP to full-length H3-NCP (H3FL-NCP) is shown by western blot analysis
for all 32 modifications. The yield for each modification was determined by quantification of
western blot analysis with n= 3-5 reactions/modification and plotted with the standard devia-
tion as error bars in figure 3.4 (C). Synthesis of H3-peptides, SrtA reaction and analysis was
performed by D. Aparicio Pelaz (Eberhard Karls Universität, Tübingen). Thus, we were able
to ligate H3 histone tails of 32 different PTM patterns with immobilized H3∆-NCP using SrtA
with an over all yield of 83±3 %. This meant, on average 17 % of non-ligated H3∆-NCP ma-
terial was present within each H3-NCP library. In order to evaluate the impact of non-ligated
H3∆ material within each experiment an H3∆-NCP control was included into the library.
3.2.2 Histone H2A: protein trans-splicing
In order to address H2A histone type specific, PtS was chosen. Here, the C-terminal part
of the evolved M86 split-intein (IntC) was genetically fused to the globular domain of H2A.
The H2A tail amino acids 1-18 and IntN (11 aa) were synthesized by SPPS. Firstly, we
were interested whether protein trans-splicing worked in the context of NCP and whether
this complex remained stable throughout the ligation procedure. To test this, a short peptide
sequence (KKESG) was labeled N-terminal with FAM and linked C-terminal to IntN. Protein
trans-splicing was allowed to proceed over 24 h (figure 3.5). The SDS-PAGE fluorescence
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Figure 3.4: Sortase A mediated ligation of H3-NCP library performed on average with
a yield of 83±3 %
Western blot analysis of SrtA mediated ligation of H3 peptide library member
1-32 was performed by D. Aparicio Pelaz. (A) Schematic representation of SrtA
mediated ligation in the context of immobilized ligation-ready NCP. (B) Western
blot analysis of SrtA mediated ligation between 32 modified H3-peptides with
H3∆-NCP using αH3 antibody recognizing both, H3∆ and the ligation product
full-length H3 (H3FL). (C) Quantification of SrtA mediated ligation with n=3-5
reactions per modification. Standard deviation is depicted as error bars.
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analysis in figure 3.5 (C) showed after 3 h reaction the formation of a FAM-labeled prod-
uct. The observation of the same reaction with native agarose gel electrophoresis revealed
IntC H2AIntN
FAM + FAM H2A
(A)
(B)
0 3 6 9 24
NCP
IntC-H2A




























Figure 3.5: Protein trans-splicing in context of NCP using FAM-IntN peptide
(A) Schematic representation of protein trans-splicing in context of NCPs. (B)
Native agarose gel observing PtS dependent conversion of IntC-H2A-NCP WT-
like-NCP product within 24 h. (C) The polyacrylamide gel shows formation
of FAM-peptide-H2A-NCP the splice product (SP) after 3 hours, P: FAM-IntN-
peptide. ◦: free DNA and side products originating from unsaturated NCP recon-
stitution.
after 3 h reaction a fast migrating complex on the same height as WT-NCP. After 24 h, IntC-
H2A-NCP was almost consumed and a complex had formed that co-migrated with WT-NCP.
Fluorescent splice product was only formed with IntC-modified NCPs. NCP species (labeled
with ◦) which migrateted between IntC-H2A-NCP and splice product originated from unsat-
urated NCP reconstitution. Hence, it was present already at the beginning of the splice
reaction and was observed as well after NCP reconstitution (figure 3.3).
Next, we asked whether the native H2A1−18-IntN was able to perform PtS in nucleosomal
context. To this end, PtS was performed under ligation conditions with both FAM-IntN and
H2A-IntN peptides over 24 h along with a control for IntC-H2A-NCP stability. It is shown in
figure 3.6 (B) for FAM-IntN peptide, that most of the product had formed after 4 h of incuba-
tion and only little initial IntC-H2A-NCP complex remained. However, using native H2A-IntN
peptide, complete consumption of IntC-H2A-NCP educt was observed after 4 h. All initial
IntC-H2A-NCPs seemed to be converted into the faster migrating wild type like NCP com-
plex. IntC-H2A-NCPs without the addition of IntN-peptides (mock control) were stable under
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Figure 3.6: Protein trans-splicing in context of NCP using native H2A-IntN peptide
Protein trans-splicing (PtS) was performed in solution in context of NCP using
different IntN-peptides analyzed by native agarose gel electrophoresis and west-
ern blot. (A) PtS in context of NCP using non-native FAM-KKESG-IntN peptide
or native H2A-IntN. (B) Native agarose gel of PtS in context of IntC-H2A-NCP
using FAM-IntN, H2A-IntN or no IntN construct (mock control) reaction was mon-
itored by agarose gel electrophoresis. (C) PtS over 4 h with H2A-IntN and IntC-
H2A-NCP, analyzed by ponceau staining and western blot against H2A displays
decrease of IntC-H2A educt and increase of splice product.




PtS reaction conditions over 24 h. The identity of the formed species was clarified by western
blot analysis of the PtS reaction over 4 h. The formation of full-length histone H2A (H2AFL)
concomitant with the consumption of IntC-H2A-NCP educt was seen within 4 h of PtS re-
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Figure 3.7: Ligation of H2A-library in context of IntC-H2A/H3∆-NCP by PtS
PtS in the context of NCP using native TMARA-H2A-IntN peptide decorated with
PTM (A). (B) Optimized PtS in solution with TAMRA-H2A-IntN peptides carrying
PTMs and IntC-H2A/H3∆-NCP analyzed with SDS-PAGE, detected by CBB and
in-gel TAMRA fluorescence and was performed by D. Aparicio Pelaz.
and PTMs of H2A. In figure 3.7 (B) the PtS reaction is displayed of H2A-IntN carrying 8
different PTM patterns with double modified IntC-H2A/H3∆-NCP over 72 h. The analysis
of IntC-H2A/H3∆-NCP conversion to modified H2AFL/H3∆-NCP was performed by SDS-
PAGE and stained with CBB. In addition, splice product was identified by fluorescence of
TAMRA-labeled H2AFL. TAMRA-H2A-IntN peptide synthesis, the ligation of these peptides
to IntC-H2A/H3∆-NCP using PtS as well as the analysis of this reaction was performed by
D. Aparicio Pelaz (Eberhardt Karls Universität, Tübingen).
Taken together, using SrtA mediated ligation for H3 and PtS for H2A we were able to generate
a library with a complexity of 8 (H2A) x 32 (H3) = 256. As the ligation of H2A needed further
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quantification of its efficiency, biochemical binding and activity assays were developed using
the H3-NCP library.
3.3 General assay development
3.3.1 Immobilization of NCPs on 96-well plate
For convenient handling and easy separation of NCP from reactants during H3-NCP library
generation and subsequently analysis, NCPs were immobilized on streptavidin-coated high
binding capacity 96-well plates (BA plates) or streptavidin coated 96-well Flash plates. At first
we were interested in the incubation time wich resulted in highest Cy5-fluorescence thus in
highest NCP immobilization of biotin-labeled Cy5-NCPs within streptavidin coated plates. To
this end, NCPs were immobilized at RT for one hour, for two hours and over night. Unbound
Cy5-NCP was removed and in-well Cy5-fluorescence was observed of bound Cy5-NCP in
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Figure 3.8: Cy5-NCP immobilization and analysis of NCP capture over 19 BA- and 8
Flash-plates
Cy5-NCP immobilization was observed in (A) by measurement of in-well Cy5-
fluorescence in dependence of varying NCP incubation time: over night (ON),
2 h and 1 h. Error bars represent the standard deviation of three replicates.
(B) Native agarose gel of Cy5-NCP input material before each coating cycle for
10 plates served as quality control on NCP integrity. (C) Overview of the standard
deviation (SD) for load and capture of NCPs per plate for BA- and Flash-plates.




most intense Cy5-fluorescence implying highest capture of NCP per well. After one and two
hours of incubation 76 % and 85 % of the final NCP capture was detected, respectively. This
result allowed us to choose between long and short incubation times if necessary.
In order to provide a good basis for the best signal-to-noise ratio for additional studies on
immobilized and post-translational modified NCP, we chose ON incubation for coating initially
10 BA-plates with H3∆-NCP in a coating volume of 50µL/well. The immobilization was
simultaneously performed on two plates in six coating cycles. As unbound H3-NCP was
reused in each coating cycle, their integrity was analyzed by EtBr-stained native agarose
gel electrophoresis (figure 3.8 (B)). We observed stable and intact H3∆-NCP for the coating
procedure for all 10 plates. This way, we assured that unbound H3∆-NCP could be reused.
Next, we asked how NCP capture varied within one plate. To this end, the developed NCP
immobilization procedure was used to coat 19 BA plates and 8 Flash plates with H3∆-NCP.
The plates were analyzed in terms of loading (15 BA-plates) and resulting capture (19 BA-
plates and 8 Flash plates, see figure 3.8 (C)). Homogeneity of load and capture over one
plate was reflected by the relative standard deviation of Cy5-fluorescence signal. The loading
within one plate varied by 9.3 %. Whereas, the variation for captured NCPs per plate was
slightly wider: BA-plates SD=15.3 % and Flash plates SD=16.1 %. So, we could assure for
homogeneous capture of intact H3∆-NCP using described immobilization protocol. However,
normalization with respect to the Cy5-NCP signal of each well would gain independency of
well-to-well coating variation in further experiments with immobilized NCPs.
In order to assure high NCP content in each well and low well-to-well variation, we asked
how the NCP load concentration influenced the binding of NCPs to the plate (capture). In
addition, we were interested in how well the Cy5-fluorescence reflected the true NCP im-
mobilization. To address this, we used two different methods for NCP quantification: in-well
Cy5-fluorescence referenced to Cy5 calibration wells on the plate (figure 3.9 (B)) and western
blot analysis of immobilized NCPs quantifying H3∆ from same wells (figure 3.9 (C - E)). In or-
der to assure western blot analysis in the linear range of detection, samples were separately
analyzed that originated from wells with high concentrated NCP input (4-32µM) and low con-
centrated NCP input (0.25-2µM). As a reference for quantification of immobilized H3∆-NCP,
the 30 pmol histone H3∆ reference sample was used. Hence, the intensity of this band was
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Figure 3.9: Single-well quantification of Cy5-NCP immobilization on BA-plates via in-
well Cy5-fluorescence and western blot analysis
Quantification of immobilized NCP per well in dependence of Cy5-NCP input
concentration (loadµM) by means of Cy5-NCP in-well fluorescence and western
blot analysis of immobilized NCP. (A) Flow scheme for quantification of immo-
bilized NCP. (B) Quantification of in-well Cy5-NCP fluorescence by means of
Cy5-reference wells with R2 = 0.99. (C) Western blot analysis of wells with NCP
load concentrations between 4-32µM (D) Western blot analysis of wells with
NCP load concentrations between 0.25-2µM. (E) Quantification of band inten-
sities by western blot analysis using ImageJ software and and their calibration
to the band intensity of 30 pmol histone H3∆ which represents 15 pm Cy5-NCP.
In (B-E) replicates are depicted: replicate #1 (blue diamond), replicate #2 (red
square) and replicate #3 (green triangle). (F) Direct comparison of NCP cap-
ture quantification between in-well Cy5-fluorescence and western blot analysis.
Shown is the mean of data points in (B) and (E) for fluorescence and western




in the range of samples originating from high concentrated NCP input and presented in the
western blot analysis of samples originating from low concentrated NCP input.
In-well fluorescence quantification revealed for low concentrated NCP load samples (0.25-
2µM) a capture of 2.0-3.5 pmol NCP per well and for high concentrated NCP load samples
(4-32µM) 6-10 pmol NCP per well (figure 3.9 (B)). The NCP quantification of wells coated
with low (0.25-2µM) and high (4-32µM) concentrated NCP input using western blot analysis
(figure 3.9 (C,D)) detected 5-10 pmol and 10-27 pmol NCP per well, respectively.
The comparison of NCP capture gained by each detection method revealed in the low con-
centration range (0.25-2µM) an input dependent NCP capture. More concentrated NCP load
led to saturated levels of NCP capture. Within the range of 4-32µM NCP load, on average
8±1.5 pmol per well were quantified by in-well Cy5-fluorescence and 20±8 pmol per well by
western blot analysis (figure 3.9 (F)). Between these two quantification methods we observed
a 2 and 2.5 fold difference in NCP capture for NCP immobilization using low and high con-
centrated NCP load. Therefore, we concluded that the detection of in-well fluorescence of
Cy5-NCP reflected the immobilized material. In addition, in-well fluorescence quantification
seemed to be more sensitive than western blot analysis although it remained to be investi-
gated which method revealed the true NCP capture per well. Besides, we could take from
these experiments that the optimal input concentration was in the range of 4µM. This was
an excess of 1.75 over available binding sites.
For further evaluation of the observed 2-2.5 fold difference in NCP immobilization detected
by Cy5-NCP in-well fluorescence quantification and western blot analysis and because of
a limited sample size in the previous experiment, NCP immobilization was determined by a
third method: determination of the concentration of loaded and unbound NCP by the DNA
absorbance at 260 nm. The difference in load and unbound NCP sample (∆A260 = A260(load)
– A260(unbound)) reflected the immobilized NCP for one coating cycle. Therefore, 34-39
wells were coated simultaneously in one NCP immobilization step as described in chap-
ter 2.3.6. This way, in total 6 immobilization cycles were performed. An initial NCP load
concentration of 3.3µM was chosen to explore the range between the previously described
low (0.25-2µM) and high (4-32µM) concentrated NCP load dependent immobilization pro-
cedure. As the unbound NCP of the preceding immobilization cycle was the input of the
subsequent immobilization cycle, the concentration decreased over 6 cycles to 1.2µM. The
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mean of NCP immobilization per well deduced from direct in-well Cy5-fluorescence and indi-




Figure 3.10: Quantification of NCP immobilization in 34-39 wells via in-well Cy5-
fluorescence and ∆A260 absorbance
It is shown the mean immobilization degree over 34-39 wells determined by
in-well Cy5-fluorescence and DNA absorbance at 260 nm: ∆A260=A260(load)-
A260(unbound) of pooled load and unbound material. Shown are 6 NCP immo-
bilization cycles with NCP load concentrations from 3.3-1.2µM. The standard
deviation from three replicates is depicted as error bar.
only little variations of NCP capture (4.4-6.4 pmol per well). Similar low variations were ob-
served for the indirect (∆A260) determination of NCP capture (18 pmol per well). In contrast,
the capture dropped to 10 pmol NCP per well for an input concentration below 1.9µM NCP.
Using the direct and indirect quantification method, a 3 fold difference was observed be-
tween Cy5- and ∆A260-quantification in the range of 3.3-1.9µM load and a 2 fold difference
for lower input concentrations. Taken together, the results of the three quantification methods
in-well Cy5-fluorescence, western blot analysis and indirect determination of NCP concen-
tration by ∆A260 pointed out, that the true NCP-coverage within each well was 2-3 fold higher
than identified by in-well Cy5-fluorescence of captured NCP. Although shifted, in-well Cy5-
fluorescence correlated with NCP capture, therefore this signal was used for normalization
of NCP content per well.
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3.4 Development of a binding assay with fluorescence readout
With ligation-ready NCP immobilized in 72 wells, we were able to introduce by Sortase A
mediated ligation any histone H3 tail modification we had prepared by SPPS. For the assay
development and characterization we chose to attach H3K9me2 and H3um peptides to im-
mobilized ligation-ready NCP. As a binding protein we chose the well-characterized HP1β
which does not bind to H3um peptides but binds to H3K9me2 peptide with a KD of 3µM [33].
In order to monitor for HP1 binding, eCFP was linked to HP1 (eCFP-HP1). ECFP has an
excitation maximum at λ= 433 nm and emission maximum at λ= 476 nm [135], which allowed
us to detect eCFP-HP1 binding modified NCP via eCFP fluorescence. Moreover, to control
for NCP coverage in each well ’147’-DNA was labeled with the fluorogenic probe Cy5. Cy5
has an excitation maximum at λ= 649 nm and emitts at λ= 670 nm [136].
3.4.1 Proof of principle experiment
The principle idea of the HP1 binding assay was whether we could observe via in-well flu-
orescence the selective binding behavior of eCFP-HP1 to H3K9me2- and H3um-NCP im-
mobilized in 96-well plates. In order to check the feasibility of the experimental design,
eCFP-HP1 was incubated on BA-plates with immobilized H3um-, H3K9me2-NCP and no
NCP (mock control) over night. As we were uncertain how washing of the wells affected
the eCFP-HP1 signal, eCFP- and Cy5-fluorescence was measured after each washing step
(figure 3.11 (B-C)). After 5 washes, bound material was analyzed by western blot (fig-
ure 3.11 (D)). Plotting eCFP fluorescence against the wash steps for H3um, H3K9me2 and
no NCP (mock control) a general drop in signal intensity was observed for all conditions. This
was expected because HP1 binding is reversible. The equilibrium between bound and un-
bound material would adjust after every wash step. Therefore, a minimum number of washes
should be applied. In this experiment at least three wash steps were necessary to remove
eCFP-HP1 from wells without NCPs (mock control) (figure 3.11 (B)). In figure 3.11 (C) the
eCFP-HP1 recruitment is plotted against the NCP content of each well displaying different
binding intensities to H3um- and H3K9me2-NCP. This same specificity of HP1 binding was
observed by western blot analysis of bound material (figure 3.11 (D)). With both detection
techniques, specific recruitment of eCFP-HP1 to H3K9me2 modified NCP was observed.
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Figure 3.11: Proof of principle assay design: eCFP-HP1 recruitment by immobilized
H3K9me2- and H3um-NCP observed by in-well fluorescence and western
blot analysis
(A) Schematic representation of eCFP-HP1 binding to H3 modified NCP immo-
bilized on solid support (plate). (B) Presence of eCFP-HP1 in wells contain-
ing H3um-NCP, H3K9me2-NCP and no NCP (mock control) after each wash
step. (C) eCFP-HP1 fluorescence normalized to NCP content after each wash




Taken together, fluorescence and western blot analysis revealed the feasibility of the princi-
ple layout of the binding assay.
3.4.2 Elucidating experimental conditions: time and washing steps
Because over night incubation might be unsuitable for proteins less stable than HP1, we were
interested in the effect of incubation time on signal intensities. To this end, on the plate im-
mobilized H3um-NCP and H3K9me2-NCP were incubated with eCFP-HP1 for 5, 30, 60 and
180 min, washed, and measured in PBS as described in detail in chapter 2.4.3 and schemati-
cally represented in figure 3.12 (A). The eCFP fluorescence after indicated wash steps for the
incubation time of 180 min is plotted in figure 3.12 (B). As observed before in the proof of prin-
ciple experiment, wash steps influenced the signal intensities and led to a smaller standard
deviation for unspecific interactions (binding to NCP-H3um). Moreover, eCFP-HP1 signal
normalized with respect to the NCP signal and plotted against the incubation time showed
a discrimination between H3um and H3K9me2 already after 30 minutes (figure 3.12 (C)).
In addition, peptide pull-down was performed using peptides (pH3um, pH3K9me3) bound
to beads and they were incubated for 1.5 h-ON with eCFP-HP1. Under these experimen-
tal conditions discrimination between pH3um and pH3K9me3 was observed for incubation
times of 1.5-4 hours. Over night incubation led to weak interaction signal of eCFP-HP1 with
pH3um (figure 3.12 (D)). From these results we concluded, that long incubation times led to
high eCFP-HP1 recruitment. However, recruitment to H3um was also increased. In few wells
coated with H3um-NCPs, HP1 was resistant to washing (see appendix figure 5.1). These
cases were identified as outliers and were removed from further analysis. In order to ob-
tain highest signal intesities in further experiments, we chose to incubate eCFP-HP1 with
immobilized NCPs over night.
3.4.3 Library design
At this stage, we started to generate the first library on BA- plates in 96-well format with only
H3-NCP modifications. The library consisted of 32 different NCP species with one to five
modifications on one histone H3. H3 tail peptides were synthesized for all 32 modifications.
These were ligated to immobilized ligation-ready NCPs using enzymatic Sortase A mediated
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Figure 3.12: ECFP-HP1 signal intensity depended on incubation time and wash steps
(A) Schematic representation of experimental set up: eCFP-HP1 was removed
after 5, 30, 60, 180 min of incubation time with n=3 wells/incubation time. Fluo-
rescence measurement took place in PBS with wash steps in between of high
salt and detergent containing buffers. (B) Influence of washes on eCFP-HP1
recruitment normalized with respect to NCP content. (C) eCFP-HP1 recruit-
ment in dependence of incubation time after the 4th measurement. (∗) Outliers
were removed on grounds of resistance to washing (see appendix figure 5.1).
Standard deviation between replicates is depicted as error bar. (D) Peptide
pull-down with pH3K9me3 and pH3um with eCFP-HP1 indicated incubation
time. Abbreviation N-term.: N-terminus of H3 peptides WB: wash buffer.
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ligation (done by D. Aparicio-Pelaz, Eberhard Karls Universität Tübingen). 2/3 of a plate were
coated with NCP-H3∆ and two libraries were ligated in a random pattern, leaving one column

































































Figure 3.13: Layout of BA-plate and H3-NCP library
(A) Displays layout of BA-plate with two libraries. Modifications were placed in
a random pattern within the library #1 and #2 area, 1/3 of the plate was kept
for controls e.g. H3∆-NCP-, and dye references. (B) H3-NCP modifications of
library #1 and #2.
3.4.4 ECFP-HP1 binding assay on H3-NCP library
Having established the parameters for the binding assay, we were interested in how eCFP-
HP1 performed on other H3-NCP modifications. In order to obtain highest signal intensities,
we chose to perform the HP1 binding assay on one H3-NCP library over night (for detailed
protocol chapter 2.4.3 on page 41). In figure 3.14 the relative fluorescence intensities of
eCFP-HP1 to Cy5-NCP is plotted for each modification and corrected for background and
gain (for detailed data analysis see chapter 2.4.5). With the assay we observed a three fold
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higher binding of eCFP-HP1 to H3K9me2 than H3K9me2S10ph. As the methyl/phos-switch
double modification H3K9me2S10ph is known to prevent HP1 binding to the methylated ly-
sine [33;78], the observed difference in eCFP-HP1 binding was expected and served as an
additional control to evaluate assay performance. Unspecific interactions were monitored by

































































































































































































































































































































































































































































































































Figure 3.14: Recruitment of eCFP-HP1 to H3 modified NCP library
H3-NCP library was probed with eCFP-HP1 over night, fluorescence data for
eCFP-NCP and Cy5-NCP were corrected for background and gain. ECFP-
HP1 was normalized with respect to Cy5-NCP fluorescence intensities per well.
[a.u.] arbitrary unit.
Thus, the question arose whether this and other prominent signals were true or false positive
values. As shown before, HP1 barely interacted with H3um, this is well defined [33;77] and
marked this value as false positive, therefore questioning all prominent signals.
In order to reduce false positive values, the subsequent experiments were conducted on
plates where the libraries were blocked with BSA and ssDNA prior HP1 incubation. In order
to calibrate eCFP and Cy5-fluorescence, reference samples for each fluorophore were intro-
duced (for details see chapter 2.4.3). As we have determined before, washing conditions in-
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fluenced strongly the signal intensity. Hence, we needed an internal reference accounting for
the differences in incubation time and washing conditions between plates and experiments.
H3∆ for example, seemed to be a good candidate for monitoring unspecific binding of eCFP-
HP1 to the nucleosome core. Therefore, fluorescence signals above H3∆ had to be caused





































































































































































































































































































































































































































































































































Figure 3.15: ECFP-HP1 binding assay performed on H3-NCP libraries.
ECFP-HP1 binding assay performed on pre-blocked libraries. Depicted is the
recruitment of eCFP-HP1 per NCP normalized to H3∆-NCP (∗) for each libray.
Library #1(blue) and #2 (red) are located on the same and #3 (green) on a
separate plate.
three libraries. Replicate #1 and #2 were conducted on libraries that shared the same plate.
The recruitment of HP1 per NCP normalized with respect to H3∆ is presented in figure 3.15.
Again, focusing on the HP1 discrimination of H3K9me2 over H3K9me2S10ph the difference
was here 2-3:1 almost as prominent as before. Although HP1 recruitment to H3um-NCP was
less intense than previously, the difference to H3K9me2 was at the best, twofold. Moreover,
reproducibility of HP1 recruitment to a range of modifications was moderate. With the binding
assay developed to this stage only trends of NCP-modification dependent HP1 recruitment
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could be detected. With n=3 per modification it was impossible to identify false positive or
negative signals.
3.4.5 Releasing NCPs into solution using the restriction enzyme EcoRI
Next, we were interested whether the ratios between specific and unspecific binding could be
increased. Firstly, by raising the eCFP-HP1 input concentration. Secondly, by reducing the
stringency of wash steps and third, by releasing bound NCPs into the solution using EcoRI.
EcoRI cuts at the enzymatic recognition site introduced between the biotin-tag and the ‘147’-
positioning sequence. Upon addition of EcoRI and hereby releasing NCP and eCFP into
solution, we expected a more efficient detection and thereby an enhancement of the fluores-
cence signal intensities. To this end, one library was probed with eCFP-HP1 using an high
input concentration, incubated over night and washed with excess of less stringent (low salt)
wash buffer. Recruitment of eCFP-HP1 to Cy5-NCP was detected, showing low discrimina-
tion between all modifications (figure 3.16 (A)). The release of NCPs and their binding part-
ner eCFP-HP1 into solution had no significant impact on the recruitment ratios of eCFP-HP1
binding to H3K9me2, H3K9me2S10ph, as well as H3um.
To determine to what extend the eCFP- and Cy5-fluorescence contributed to this observation,
eCFP-HP1 in pmol and Cy5-NCP in pmol were separately plotted before and after EcoRI
treatment in figure 3.16 (B, C). For eCFP-HP1 and Cy5-NCP more molecules were available
for detection after EcoRI treatment. While the absolute value of eCFP-HP1 binding depended
on the initial detected amount before EcoRI treatment, we observed an increase in detected
molecules per well of 10±3 % upon release. In contrast, for Cy5-NCP on average 5 pmol per
well after EcoRI treatment were detected which were not observed before EcoRI treatment
for several modifications of H3-NCP by releasing Cy5-NCP into solution. The treatment
revealed an evenly Cy5-NCP coverage for all modifications.
Taken together, we could enhance the detected fluorescence signal for eCFP-HP1 and Cy5-
NCP. However, this had little effect on the relative recruitment of HP1 per NCP. Moreover,
an increase in HP1 loading concentration and less stringent washes led to an increase in
unspecific interaction rather than increased specific binding. The specificity in HP1 binding to















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.16: ECFP-HP1 binding assay on H3-NCP library before and after release
Binding assay performed on H3-NCP library, subsequently immobilized NCP
were released using restriction enzyme EcoRI (A) Recruitment of HP1 per NCP
normalized to H3K9me2S10 (∗) before (blue) and after (red) EcoRI treatment.
(B) ECFP-HP1 signal before (light green) and after (dark green) EcoRI treat-
ment. (C) Cy5-NCP signal before (light blue) and after (dark blue) EcoRI treat-
ment.
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was less than observed before. Hence, it was necessary to further optimize the experimental
set up for an increased specificity of HP1 binding.
3.4.6 Optimization for better signal-to-noise ratio: experimental procedure
Although specific binding of HP1 to H3K9me2 compared to H3K9me2S10ph was observed in
figure 3.15, the major concern was the high binding events of eCFP-HP1 to H3um-NCPs. To
address this, peptide pull-down was chosen for optimization of buffer conditions at different
stages of the experiment: peptide immobilization, protein-peptide incubation and removal of
unbound protein. The buffer conditions for protein/peptide incubation and wash steps were


























































































































































Figure 3.17: Optimization of block- and buffer-conditions during protein incubation
and wash steps
Optimization was performed on histone peptide pull-down with protein incuba-
tion over night (A) Western blot analysis of peptide pull-down for eCFP-HP1
and HP1 under optimized (Opt) and in the binding assay used conditions (BA).
(◦) cross contamination introduced during washing. (B) Western blot analysis
of 1% input of each condition shown in western blot (A).
peptide immobilization step only buffers with or without BSA were tested. The western blot
analysis in figure 3.17 (A) shows a peptide pull-down experiment with conditions used in the
binding assays and the optimized buffer conditions. ECFP-HP1 bound similar to pH3K9me3
in both buffer conditions. The difference was here their binding to H3um peptide (pH3um)
and mock control (no peptides on the beads). However, the transfer of these conditions to
the binding assay in the plate with NCPs failed. Using the optimized washing conditions
led to signals close to background noise. Only the reduction in ionic strength (150 mM) in
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combination with increased washing volume (4xNCP coating volume) resulted in a two fold
difference in recruitment of eCFP-HP1 to H3K9me2-NCP over H3um-NCP.
3.4.7 Optimization for better signal-to-noise ratio: brighter fluorophores
In order to enhance signal-to-noise ratio, we used brighter fluorescence proteins. Derivatives
of eCFP such as mCFP and Cerulean which differ relatively to eCFP only in few amino acids
mCFP=eCFP/A206K and Cerulean=eCFP/S72A/Y145A/H148D [135]. mCFP is reported to
have a brightness of 13 (product of extinction coefficient and quantum yield divided by 1000)
whereas Cerulean’s brightness is 27 which is relative to eCFP 1.2 and 2.5 fold brighter, re-
spectively. However, the photo-stability, that is the time in seconds to reach half maximal
emission intensity, is reported for mCFP with 64 sec and for Cerulean with 36 sec. Whereas
the bleaching time for eCFP is reported to be 70 % of Cerulean’s thus 27 sec [135;137]. Hence,
it was hard to foresee whether photo-stability would overrule fluorescence intensity or vice
versa. This question was addressed experimentally, eCFP-HP1, mCFP-HP1 and Cerulean-
HP1 were tested using the optimized conditions. Because all CFP derivatives had similar
excitation end emission spectra, experiments were performed on the same plate and mea-
sured at the same time. The eCFP and Cy5-fluorescence were converted into pmol and
normalized with respect to the NCP coverage within each well. This way, the recruitment
of CFP-HP1 per Cy5-NCP was obtained. In figure 3.18 is plotted the recruitment of eCFP-,
mCFP- and Cerulean-HP1 which bound to H3um-, H3K9me2- and H3∆-NCPs. The recruit-
ment of eCFP-HP1 and mCFP-HP1 by H3K9me2 was similar with 3.5 HP1 per NCP and
≤1.5 HP1 per NCP for H3um and H3∆. In contrast, Cerulean-HP1 bound in general less
to modified and unmodified NCPs. Here, the recruitment to H3K9me2 modified NCPs was
1.5 HP1 per NCP and < 0.5 HP1 per NCP for H3um-NCP and H3∆-NCP. The western blot
analysis of immobilized and bound material reflected the general observation made by fluo-
rescence measurement.
Overall, western blot analysis revealed very similar recruitment by H3K9me2 for all three CFP
derivatives. The little recruitment of Cerulean-HP1 to modified NCP observed by in-well fluo-
rescence detection was not detected by western blot analysis. The relative CFP-HP1 recruit-
ment to the according H3∆ (∗) is plotted in figure 3.18 (C) for both replicates. It showed an
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Figure 3.18: Binding assay under optimized conditions using CFP-HP1 derivatives for
binding to H3K9me2 and H3um NCP
Binding assay performed in duplicates using optimized assay conditions. (A)
Recruitment of HP1/ NCP for eCFP-, mCFP- and Cerulean-HP1 of replicate #1.
(B) Western blot analysis of bound material for replicate #1. (C) HP1 per NCP
recruitment normalized to H3∆(∗) for both replicates.
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equal 2.5 fold difference between H3um and H3K9me2 for eCFP- and mCFP-HP1 whereas
the signal-to-noise ratio seemed better for Cerulean due to the low recruitment of Cerulean-
HP1 by H3um-NCP. The in-well fluorescence and western blot analysis of Cerulean-HP1 did
not match. This suggested quenching of the fluorophore. ECFP and mCFP had shown to
be similar recruited by H3K9me2, H3um-, and H3∆-NCP by both in-well fluorescence and
western blot analysis. Therefore, both proteins were suitable for further assays. Up to this
point, no gain in specific recruitment by H3K9me2 over H3um was achieved by the use of
brighter CFP derivatives.
3.5 Development of an activity assay based on radioisotope
labeling readout
For the activity assay, ligation-ready NCP were immobilized on streptavidin coated 96-well
Flash plates. Flash plates carried a coating of a thin polysterene layer containing the scintil-
lant. Thus, radiation from proximate radioisotopes were converted into photons which could
be detected by the plate reader and no additional scintillation cocktail was necessary.
3.5.1 Library design
In order to study the influence of an additional positively charged PTM on potential GCN5
target sites and neighboring target sites of Aurora B, we expanded the H3-NCP library by
three members: H3K4ac, H3K9ac and H3K27ac. Together with H3∆, they were placed on
the so far un-used NCP-H3∆ coated column (see figure 3.19). For NCP coverage determi-
nation, reference wells for Cy5 were placed. Background radioactivity was also determined
using as a negative control wells without NCP-coating which were treated with the reaction
mix.
3.5.2 HAT assay development using GCN5
The histone acetyltransferase GCN5 acetylates the histones H3 and H4 in non-nucleosomal
context with preference for H3K4me3 modified histones [138]. GCN5 within the SAGA com-
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Figure 3.19: NCP-H3 library with additional acetylation on H3K4, H3K9 and H3K27
(A) 96 well plate organization of randomized Library #1 and #2, with wells for
calibrating Cy5-fluorescence (calibr. Cy5). (B) PTM patterns of combinatorial
NCP-H3 library with 36 members.
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plex augments HAT activity and acetylates histones within the NCP [59]. In addition, recom-
binant GCN5 was found to acetylate nucleosomal substrates in vitro under certain condi-
tions [58]. With respect to the different acetylation behavior towards histones within the NCP,
we wanted to see whether the experimental set up was able to observe the incorporation of
radioisotope labeled acetyl groups onto immobilized NCP by the HAT GCN5 in Flash plates
(figure 3.20 (A)). To this end, NCPs containing wild type histones (WT-NCP, for octamer
and NCP reconstitution see Appendix figure 5.2) were immobilized with a coating volume
of 200µL and the HAT assay was performed (figure 3.20 (B)). We observed GCN5 depen-
dent incorporation of 14C-labeled acetyl-groups into the NCP in the absence of either GCN5
(– GNC5) or NCP substrate (BG), only little background signal was observed. Concluding,
we were able to detect GCN5 dependent acetylation of WT-NCP immobilized on Flash plates.
Streptavidin coated Flash plates had a biotin binding capacity of ≈40 pmol/well with a strep-
tavidin coating volume of 200µL. Thus, the streptavidin coating density was lower compared
to the BA-plates (biotin binding capacity: 125 pmol/well in 100µL coating volume). As the
coating volume defined the amount of immobilized NCP, we were interested in how much
the NCP immobilization degree would decrease by the reduction of the NCP coating sur-
face. To this end, WT-NCP were immobilized with 50, 100 and 200µL coating volume into
96-well Flash plates while NCP coverage was observed by in-well Cy5-fluorescence (see
figure 3.20 (C)). With fluorescence readings normalized with respect to 200µL, the fluores-
cence intensities of Cy5-NCP coverage within the well showed 55 and 62 % signal intensity
for 50 and 100µL Cy5-NCP coating volume. While the difference of NCP coverage for 50
and 100µL correlated with the theoretical available surface of 50 and 100µL, there was a
loss in signal intensity of 40 % between 100 and 200µL Cy5-NCP coating volume. Thus, the
reduction of the coating volume by a factor of 0.5 and 0.25 resulted in 62 and 55 % of NCP
coverage. Therefore, it seemed more efficient to use either 50 or 100µL coating volume for
NCP immobilization.
The main interest however, was to find the minimal NCP coating volume where a stable and
good acetylation signal could be obtained. To this end, GCN5 dependent acetylation with
14C-labeled AcCoA was performed on WT-NCP in 50, 100 and 200µL reaction volume (fig-
ure 3.20 (D)). Signal intensities were corrected for background and counts were normalized
with respect to the acetylation counts in 200µL reaction volume. The observed NCP acety-
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Figure 3.20: The acetylation of immobilized WT-NCP by GCN5 was observed using
Flash plates
(A) Schematic representation of HAT assay with NCP immobilized on Flash
plates, which have the scintillant incorporated into the well. Scintillant con-
verted energy of β-particle emitted by incorporated isotope (14C) into pho-
tons (λ) which were detected. (B) Acetylation of immobilized WT-NCP in the
presence (+) or absence (-) of GCN5 with NCP-coverage shown in the inset.
BG: + GCN5 in empty wells. (C) Comparison of theoretical available coating
surface in 50, 100, and 200µL coating volume (blue) and effectively covered
surface by NCP relative to 200µL coverage. Values are plotted as mean± s.d.
of 3 replicates. (D) background corrected CPM of acetylated NCPs in 50, 100,
and 200µL reaction volume relative to acetylation in 200µL. Values are plotted
as mean± s.d. of 3 replicates.
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lation in correlation with the reaction volume displayed a linear behavior. This was contrary
the expectation, that would suggest a correlation between NCP coverage and acetylation
signal. Nevertheless, for 100µL both NCP coverage and NCP acetylation displayed 60 %
signal intensity relative to 200µL reaction per coating volume. Whereas the acetylation sig-
nal observed within 50µL coating surface did not correlate with NCP-coverage. 100µL NCP
or larger NCP coating and GCN5 reaction volume led to good correlation of NCP coverage
and detected acetylation degree. Thus it was chosen to work with an NCP coating volume
per GCN5 reaction volume of 100µL.
Replicate #1
Replicate #2
Figure 3.21: Acetylation of WT-NCP by GCN5 over 2 hours time course
Two replicates of HAT assay on immobilized WT-NCP by GCN5 over 120 min-
utes. Raw data was corrected for background and normalized to NCP coverage.
Next, we were interested in the time dependent acetylation of immobilized NCP by GCN5. To
this end, the GCN5 reaction mix was incubated with immobilized WT-NCP and was removed
from the plate at indicated time points. Wells were washed and the 14C incorporation and
Cy5-NCP coverage was detected. In figure 3.21 the acetylation degree per NCP is plotted in
dependence of incubation time. Acetylation of NCPs by GCN5 displayed a linear correlation
over 120 min. Thus, enzymatic acetylation of WT-NCP by GCN5 had not reached saturation.
As the acetylation degree of WT-NCP progressed the most within the observed time frame
at 120 min without saturation, the HAT assays on the H3-NCP libraries were incubated for
120 min. This way we reasoned, we would obtain the largest range for the observation of
GCN5 activity in dependence of the pre-modification of H3-NCP.
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3.5.3 HAT assay performed on H3-NCP library
Having established the parameters for the GCN5 HAT assay on WT-NCP, we were interested
in how the de novo acetylation rate by GCN5 depended on pre-modified H3-NCP. To this
end, H3-NCP libraries were incubated for 120 minutes with GCN5 and 14C-labeled AcCoA.
De novo acetylation of pre-modified H3-NCP was corrected for background, normalized with
respect to both Cy5-NCP content and the de novo acetylation degree of H3um-NCP for

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.22: GCN5 HAT assay on H3 modified NCP library
Flash plate HAT assay on H3-NCP library incubated with GCN5 for 120 min.
Raw data was corrected for background, normalized to NCP content and acety-
lation degree of H3um-NCP (∗), plotted as mean ± s.d. for 7, 6 (◦) replicates.
Arbitrary units [a.u.], (∗∗) significant p<0.05 , n.s. not significant.
acetylation rate for NCPs that contained H3K27me2S28ph compared to PTM patterns which
contained H3S10ph. The presence of both, H3S10ph and H3S28ph displayed an acetylation
degree similar to H3um. Whether H3K4 and H3K27 were acetylated or di-methylated had no
impact on the acetylation rate of GCN5. In contrast, H3K9me2 strongly decreased the GCN5
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acetylation rate compared to the pre-actylated (H3K9ac) version. Importantly, we observed
for NCPs that carried a truncated histone H3 (H3∆) no acetylation of these NCPs.
Taken together, this data present the successful development of an activity assay for screen-
ing the impact of pre-set histone PTMs on the acetylation rate of GCN5 using Flash plates
and radioisotope readout of incorporated 14C-labeled acetyl groups. We found evidence
for a new GCN5 acceleration mark H3K27me2S28ph. In comparison, H3S10ph seemed to
slow down GCN5. As a single mark, H3K9me2 had a severe impact on slowing down GCN5
acetylation on these NCPs.
3.5.4 Kinase assay with Aurora B
Kinases play a crucial role in regulating cellular processes by phosphorylation [66]. Thus,
having established the activity assay for the HAT GCN5 we were interested in applying the
experimental design for studying kinase activity in dependence of pre-modified NCP (see
figure 3.23 (A)). Here, the well characterized kinase Aurora B was chosen that is known to



























Figure 3.23: Activity assay with Aurora B on WT-NCP over 2 hours
(A) Schematic representation of kinase assay: immobilized WT-NCP were
phosphorylated by auto activated Aurora B and readout of incorporated
radioisotope-labeled phosphorylation marks. Scintillant converted energy of
β particle into photons (λ) which were detected. (B) Kinase assay performed
on WT-NCP immobilized on Flash plates for + Aurora B (red) values are plotted
as mean± s.d. of 3 replicates and - Aurora B (blue) one replicate using γ-32P-
ATP and WT-NCP as substrate. Raw data were corrected for background and
normalized to NCP content per well.
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assay conditions were tested with WT-NCP immobilized on Flash plates over an 120 min time
course. In figure 3.23 (B) the phosphorylation by Aurora B per WT-NCP is plotted against the
incubation time in the presence or absence of Aurora B. Within the observed time frame of
120 minutes, phosphorylation by Aurora B correlated linear with the incubation time. Impor-
tantly, no saturation of the system was observed. In the absence of Aurora B, as expected,
no phosphorylation was detected except for an outlier at early time points. Thus, we decided
on a 120 minutes reaction time for the enzymatic phosphorylation of the H3-NCP library by




























































































































































































































































































































































































































































































































































Figure 3.24: Aurora B kinase assay on H3-NCP library
Aurora B kinase assay performed on H3-NCP library over two hours with read-
out of incorporated 32P by Aurora B. Grouped according pre-modified (pre-
occupied) of serine phosphorylation sites. Raw data were corrected for back-
ground, normalized to NCP-content and H3um-NCP, set as 1, and marked with
(∗). Data points are plotted as mean ± s.d. of 4 replicates.
(∗∗) significant p<0.05, n.s. not significant.
tested for modification-dependent phosphorylation by Aurora B. Two libraries on each plate
were incubated for two hours with kinase reaction mix containing Aurora B and γ-32P-ATP.
The mean of incorporated 32P per NCP normalized to the phosphorylation degree of H3um-
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NCP for each library is plotted in figure 3.24. The assay showed the substrate specificity
of Aurora B, which phosphorylated H3S10 and H3S28. No further phosphorylation of NCP
was observed for NCPs that were pre-phosphorylated on these sites. As in the preliminary
experiment, we observed here as well several outliers that in part were statistically identi-
fied and removed. In addition, we detected library-to-library variations due to plate-to-plate
variations and positioning within the plate [140]. Taking a close look on NCPs which were pre-
phosphorylated on both sites (H3S10/S28), on one site (H3S10) and both available phos-
phorylation sites on H3 (0) the signal intensities for de novo phosphorylation were in line with
available phosphorylation sites. Thus, it remained open what caused the different phospho-
rylation intensities between NCPs pre-phosphorylated on H3S10 or H3S28. As expected,
neither H3∆-NCPs nor doubly pre-phosphorylated NCPs were a substrate for Aurora B.
These data clearly demonstrated the successful development of an activity assay for analyz-
ing the H3-NCP pre-modification dependent activity of Aurora B.
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The histone code hypothesis states that certain patterns of PTMs on the histone tails lead to
a specific biological outcome [49;79]. Since the formulation of this hypothesis, it is important to
decipher this code and to gain insight into the cross-talk between histone modifications within
chromatin. In order to provide a platform for the systematic study of histone PTMs in the
context of NCPs we designed a ligation-ready NCP, that allowed ligation of modified histone
tails to H3 and H2A using Sortase A and protein trans-splicing, respectively. In addition, we
developed an in vitro biochemical binding assay with fluorescence readout for studying the
impact of post-translational modified H3-NCP on the interaction with the well-characterized
HP1. The H3 histones within the NCPs were modified with one to five PTMs per histone tail in
all possible combinations. Moreover, we developed proximity-based radioactive, enzymatic
assays for studying the impact of 36 differently pre-modified H3-NCPs on the activity of the
histone acetyltransferase GCN5 and the kinase Aurora B.
4.1 Assay performance
4.1.1 Consequences of ligation in nucleosomal context for biochemical
assays
In this study we used a H3-NCP library of 36 members, that was generated by enzymatic
ligation of modified histone tails. The overall ligation efficiency for in 96-well plates immobi-
lized H3∆-NCP was 83±3 % (figure 3.4). Thus, on average 17 % remained as H3∆-NCP for
each modification. Consequently, we included the truncated, non-ligated, ligation-ready NCP
(H3∆-NCP) as a separate modification into the H3-NCP library to observe its performance
within the assays. For binding assays, this served as a good control for unspecific bind-
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ing. For the enzymatic activity assays, it was demonstrated that the non-ligated H3∆-NCP
had no impact on the enzymatic activity. H3∆-NCP was found to be no substrate for both
enzymes (Aurora B and GCN5). The incomplete ligation had only an impact on the quan-
tification of immobilized H3-NCP. Hence, the actual degree of modified, full-length H3-NCP
within each well was on average 17 % lower than determined by in-well Cy5-NCP fluores-
cence. We normalized the data with respect to the Cy5-NCP signal representing both H3∆
and H3-modified-NCP content in each well for the following reason: the assay reported pro-
tein binding or enzymatic activity on all H3-NCP modifications at the same time. Hence, we
were interested in their relative instead of absolute impact on binding or enzymatic activity.
To gain clarity of the modification degree in future libraries, we introduced a fluorescence-
tag in the H2A-tail (figure 3.7). In this manner, we plan to observe the protein trans-splicing
efficiency for generation of modified H2A-NCP by comparing it with the Cy5 signal of immo-
bilized NCP. In the case of full ligation we expect this ratio to be 2:1.
For efficient ligation, synthetic histone tails as well as recombinant histone core domains of
H3 and H2A had to be modified, which resulted in minor alterations in amino acid sequences
at the ligation sites in the final, full-length histone. For H3, the final product was H3A29L,
as this was not a site for histone PTM nor a negative or positive charge was introduced,
we assumed this mutation did not influence our assays. In agreement with this, the bind-
ing assay revealed functionality of H3-modified-NCP by selective binding of eCFP-HP1 to
H3K9me2-NCP, but not H3K9me2S10ph-NCP and H3um-NCP (figure 3.11). For H2A, pro-
tein trans-splicing using mini-split intein led to an insertion of four amino acids (GSIE) into the
final splice product. We showed that there was no difference in migration in native agarose
gel electrophoresis between spliced H2A-NCPs and WT-NCPs, suggesting full integrity of
ligated NCPs with a wild type like size (figure 3.5 (B)). Whether they are functional equivalent
to native H2A-NCP remains to be tested, as we focused on this study in the development of
biochemical assays on H3-NCP library.
4.1.2 Quantification of immobilized H3∆-NCPs
Quantification of immobilized Cy5-labeled H3∆-NCPs by in-well fluorescence compared to
plate external quantification methods (western blot, absorbance of DNA at 260 nm) resulted
in a 2-3 fold difference in detection (figure 3.9 (F) and figure 3.10). This was probably due
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to the limited availability of NCPs for spectroscopic detection within the well, while all NCPs
were solubilized using SDS containing buffer for western blot. Similarly, the entire NCP
immobilization degree was detected by the indirect determination of bound NCPs. It was cal-
culated from the difference in NCP concentration of the loaded and unbound NCP-material.
The concentration was determined by the absorbance of DNA at 260 nm (A260), suggesting
local detection of Cy5-NCPs by in-well fluorescence as well. This was probably due to a
limited excitation spot size of the plate reader (2 mm diameter, TECAN infinite Pro Manual),
which possibly did not excite molecules outside this area (e.g. molecules bound to the walls).
This was addressed by performing an eCFP-HP1 binding assay on immobilized NCPs and a
subsequent release of immobilized Cy5-NCP into solution thereby increasing the amount of
detected molecules (figure 3.16). To control for pH and temperature dependent variations of
fluorescence intensities [141], reference wells containing either eCFP or Cy5 fluorophore were
placed on the same plate (figure 3.16). A slight increase was observed in the amount of de-
tected molecules before and after release of Cy5-NCP and bound CFP-HP1 into the solution.
However, this increase did not result in the same amount of immobilized NCP as obtained
by DNA absorbance at 260 nm and western blot analysis. As the ratio of eCFP to Cy5 did
not change before and after their release into solution and the detected in-well fluorescence
was representative for the immobilization degree of NCP in each well (figure 3.16 (A)), we
reasoned the fluorescence readout would be an adequate choice for our qualitative binding
assays.
However, we could not increase the immobilization degree above 20 pmol per well (8 pmol
quantified by in-well Cy5 fluorescence), which was only one sixth of theoretically available
binding sites within 50µL coating volume. This limited the sensitivity of this detection method.
Related techniques observing interactions with immobilized probes such as Enzyme-Linked
Immunosorbent Assay (ELISA) circumvent the issue of limited sensitivity by the use of en-
zymes (e.g. horseradish peroxidase). Upon addition of a substrate a colorimetric or chemi-
luminescent signal can be observed in solution which reflects the entire well content and
not just a limited area, thus amplifying the signal [142–147]. In microtiter plate based assays
using fluorescence readout, sensitivity is limited to background fluorescence and possible
quenching effects by analyte compounds [148]. Thus, in high-throughput assay development
the focus turns towards proximity-based techniques such as ALPHAlisa, LANCE [104;106] or
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DELFIA (dissociation-enhanced lanthanide fluorescence immunoassay). DELFIA relies on
fluorescence compounds that possess a large stokes shift, resulting in wide separation of ex-
citation and emission maxima for time resolved fluorescence detection without background
fluorescence by other compounds [149;150]. A study by Schiedel et al. [151] describes that the
increase of immobilized material by immobilization to magnetic beads instead of plates re-
sults in an increase in dynamic range and robustness.
In summary, besides an higher background signal compared to proximity based set ups,
in this study the limiting factor for the sensitivity and dynamic range of the here developed
binding assay was the immobilization of Cy5-NCP and the not enzymatically amplified signal
detection.
4.1.3 Factors introducing variability
To develop a robust assay, it was not only important to increase the signal intensity by im-
mobilizing as many NCPs as possible, but it was even more paramount to guarantee the
reproducibility of the binding and activity assays. In the developed assays several factors
contributed to library-to-library and plate-to-plate variability. Firstly, the well-to-well variability
of NCP coverage determined by in-well Cy5 fluorescence was found to be 15 % for binding
assay plates (BA-plates) and 16 % for Flash plates (figure 3.8). This was in part caused by
the provided streptavidin coating by the vendor as well as by small experimental variations.
In order to minimize the variability introduced through NCP capture, the data was normalized
with respect to the H3∆-NCP content for each well determined by Cy5-in well fluorescence.
However, this only took H3∆-NCP into account, as discussed above, but not the modified
H3-NCP which depended on the ligation efficiency for each modification. Thus H3 ligation
was a source of library-to-library variation.
Secondly, in eCFP-HP1 binding assays, signal intensity depended strongly on incubation
time and wash steps (figure 3.12). Therefore, it was necessary to normalize with respect to
an experiment internal standard (H3∆-NCP). However, this was not sufficient to obtain repro-
ducible eCFP-HP1 binding results for all modified H3-NCP (figure 3.15). Possibly, inherent
properties of the HP1 protein accounted for such variability. For example, HP1 proteins are
known to dimerize via their C-terminal chromo shadow domains. Recently, it was shown that
HP1 dimer dissociation is kinetically trapped on condensed chromatin displaying high local
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concentration of H3K9 methylated tails [77]. As the ligation efficiency varied for each modi-
fication and for each conducted ligation (figure 3.4), the variability of the H3K9me2 density
might be a possible source for the observed differences in H3K9me2 binding. Whether this
was the only mechanism causing the variations between the experiments remained to be
investigated.
Thirdly, in all microtiter plate based assays, positioning effects within one plate can introduce
bias. Therefore, randomization of samples is suggested to avoid any bias introduced by a cer-
tain position [152]. For radioactivity based assays using Flash plates variations within and be-
tween columns have been reported [140]. Thus we randomized the positions of modifications
in each library in order to avoid that kind of bias. However, randomization could contribute
to library-to-library variability. With increasing energy of the radiolabel, a cross-talk between
neighboring wells could occur, which could accumulate depending on its position within the
plate. Although these effects might be small, they still contributed to library-to-library variabil-
ity. Automation of HAT and kinase assay in addition to increased sample size will probably
reduce the occurrence of outliers and provide an even better overview of library-to-library
variation, as well as identification of positive and negative effects of modified H3-NCP on
binding and enzymatic activity.
4.1.4 Specificity of assays
We found that the selective binding of eCFP-HP1 to H3K9me2 modified NCPs was identified
by in-well fluorescence readout and verified this by western blot analysis (figure 3.11). More-
over, signal intensities depended on eCFP-HP1 incubation time and wash steps. The unspe-
cific interaction of eCFP-HP1 with H3um- and H3∆-NCPs was of concern. Studies [153–155]
indicated that HP1 can also bind unmodified mono-nucleosomes which seems to depend on
DNA linker length. It is reported that the hinge region of HP1 interacts with DNA of nucleo-
some core particles. HP1α is found to bind DNA linker with a ratio of 3:1 to H3K9me3-NCP
over H3um-NCP whereas the specificity is reduced to 2:1 in the absence of linker DNA [153].
The opposite effect is observed for the HP1 homolog Swi6. Specificity of Swi6 to H3K9me3-
NCP over H3um-NCP is reduced by a factor of 5 with increasing linker length (0-47 base
pairs) [154]. However, for HP1β the DNA binding effect is reported to be weaker [156]. Addi-
tionally, it was shown recently that the unstructured N-terminus of HP1β makes contacts with
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the H3 tail and core regions instead of the HP1β hinge region with DNA [77]. These weak but
numerous interactions could to a certain degree explain the unspecific interaction of HP1β
to H3um-NCPs observed in figure 3.18. However, after optimization of the binding assay we
observed specificity of eCFP-HP1 binding H3K9me2 two to four times of eCFP-HP1 binding
H3um-NCP (figure 3.18). This was in accordance with the reported specificity of 2 and 5 fold
for HP1α and Swi6, respectively [153;154]. Why we observed an excellent specificity between
H3um-NCP and H3K9me2-NCP in the very first binding experiment by in-well fluorescence
remains an open question (figure 3.11). The dynamic range was wider than in all following
binding experiments even after optimization of the binding conditions. In contrast, western
blot analysis suggested comparable specificity between the first binding experiment and af-
ter assay optimization (figure 3.18), thus some additional fluorescence specific effects must
have contributed to the observation.
In order to increase the signal-to-noise ratio, brighter CFP derivatives were used: monomeric
CFP and Cerulean. However, this only would work in the absence of unspecific HP1 binding.
Otherwise, taking unspecific bindig of HP1 into account, both binding events, specific and un-
specific, would lead to increased fluorescence intensity resulting in a similar ratio of modified
versus unmodified NCP as we observed in figure 3.18 (C). Unexpectedly, we detected a lower
recruitment of Cerulean-HP1 to H3K9me2-NCP by in-well fluorescence compared to eCFP-
and mCFP-HP1. In contrast, western blot analysis revealed rather equal recruitment of all
three CFP-HP1 derivatives (figure 3.18 (A, B)). One explanation for this discrepancy could
be that the chromophore of Cerulean, carrying mutation S72A but no A206K for improved
protein folding and solubility, did not fully mature, thus resulting in differences in detection by
in-well fluorescence and western blot analysis.
Hence, the issue whether Cerulean could increase the signal-to-noise ratio by its potentially
enhanced spectroscopic properties was not entirely solved. Therefore, we suggest to include
the A206K mutation for monomeric Cerulean that supports folding during expression for fur-
ther studies. In need of even brighter fluorophores to push sensitivity of the assay to its limits
the use of the up to date brightest GFP derived CFP derivative mCerulean3 or mTurquoise
with a quantum yield of 0.8 are possibly a good choice. Whereas Cerulean and eCFP have
quantum yields of 0.6 and 0.3, respectively, with comparable extinction coefficients [157;158].
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On the other hand, activity assays relied on the detection of incorporated radioactive isotopes
by the enzymes GCN5 and Aurora B. The only limiting factor here was how many labels could
be incorporated into nucleosomes and how well these signal could be converted into a de-
tectable signal by the scintillant. For the GCN5 assay, the counts were rather low due to the
low energy of the β-particle of 14C compared to 32P. As these factors were inherent to the
compounds and plates, signal intensity could be enhanced by increasing the immobilized
substrate NCP (figure 3.20 (D)). As a result, ratiometric analysis of HAT and Kinase assay
revealed a good discrimination between positive (H3um-NCP) and negative (H3∆-NCP) con-
trol resulting in ratios of 13 and 10 for GCN5 and Aurora B assay, respectively. These ratios
are comparable to a Flash plate-based HAT inhibitor screen assay on immobilized histone
H3. This shows that the increase of immobilized substrate results in good assay window and
overall robustness [159].
4.2 Influence of pre-modified NCP on GCN5 and Aurora B
activity
Enzymes modifying chromatin interact either directly with chromatin or are recruited to chro-
matin by other proteins [50]. GCN5 for example acts in a two-step mechanism: at first, it
acetylates H3K14, which stabilizes its binding through engaging the bromodomain. This fa-
cilitates the second step, acetylation of other sites within H3 and hyperacetylation of H4 [60].
We observed no acetylation of the H3∆-NCP, which was in agreement with the mechanism
described above. Furthermore, no acetylation of other histones was observed in the absence
of the H3 tail (figure 3.22), which is responsible for tethering GCN5 to the nucleosome accord-
ing to Cieniewicz et.al [60]. With the assay we could observe the overall acetylation degree
in dependence of the histone H3 modification patterns, but not the exact histone which was
modified. Importantly, we could directly compare the effect of pre-modified H3-NCP on the
acetylation rate by GCN5. However, we could not detect the described [56;160;161] overall en-
hancement of acetylation by H3K4me2/3 or H3S10ph. This was probably due to the different
acetylation behavior of GCN5 alone compared to GCN5 in the SAGA or ADA complex [52;160].
Recognition of H3K4me2/3 has been assigned to a complex partner (Sgf29) within the SAGA
complex [160;162]. In previous investigations, the influence of H3S10ph on GCN5-mediated
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acetylation is found to be controversial [32]. Studies reported both an increasing effect on the
acetylation rate or no effect compared to unmodified substrates [91;161;163;164].
For the GCN5 activity assay developed in this work, we observed an enhanced acetylation
rate for H3 PTM patterns containing H3K27me2S28ph compared to single phosphorylated
modifications at H3S10 (figure 3.22). In vivo, H3S28ph and H3K27me3S28ph are linked
to transcriptional activation [81;165] and concomitant acetylation of histone H3 and H4 is ob-
served [82;165]. Thus it seemed possible that GCN5 supports transcriptional activation upon
phosphorylation of H3K27me3S28 by kinases (Aurora B or MSK1) from the repressive state
marked by methylated H3K27.
The introduction of acetylation of H3K4, H3K9 or H3K27, which are targeted by the bromod-
omain of GCN5, did not increase acetylation compared to the methylated states (H3K4me2
or H3K27me2). This was probably due to the preference of GCN5 for modifying H3K14 and
subsequently binding to this site [60]. Surprisingly, H3K9me2 greatly decreased the acetyla-
tion rate of GCN5. Although H3K9me2 is known to be located at silenced domains within
euchromatic regions and is therefore a good candidate for reducing the affinity of GCN5 to
nucleosomes, this effect has not been observed before [43]. Interestingly, in this work de-
creased acetylation by GCN5 was only observed on single modified NCPs but not when the
modification occurred in combination with H3K27me2 or H3K4me2K27me2. In any case,
effects of certain H3-NCP-PTM patterns on GCN5 acetylation rates need further evaluation
to verify the observation.
In contrast to the GCN5 assay, the activity assay performed with the kinase Aurora B clearly
showed that nucleosomes pre-occupied on both phosphorylation sites (H3S10 and H3S28)
were not a substrate for Aurora B. Pre-modification of H3S10 led to a reduced phosphory-
lation activity compared to H3-NCP modification patterns that contained unmodified serines
or H3S28ph only. This suggested that Aurora B preferred H3S10 as substrate over H3S28.
Both H3S10ph and H3S28ph are reported to be phosphorylated by Aurora B during mitosis
and have been described to be crucial for chromosome condensation and segregation. While
H3S10ph is observed from late G2 until telophase whereas H3S28ph only occurs between
prophase and anaphase, indicating that H3S28ph is regulated independently of H3S10ph,
but a mechanism has not been described [70]. Our studies suggested that the discrimina-
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tive phosphorylation of H3S28 on pre-phosphorylated H3S10 histone tails was an Aurora B
inherent property, which was possibly further regulated by other components.
In conclusion, we developed a powerful tool for determining the impact of histone PTM pat-
terns on the activity of chromatin-modifying enzymes. PTM patterns identified this way pro-
vide a good lead for further investigation.
4.3 Features and limitations of binding and activity assays
The assays developed in this study provided several advantages over previously developed
PTM screening approaches [88;104;115]. Because of the one-modification-one-well set up, we
could detect interactions independent of the use of histone PTM antibodies, whose binding
target is known to be prone to inhibition by adjacent PTMs [42]. Our assay, in contrast to
antibody-based assays, allowed the widespread, unbiased evaluation of the impact of any
combination of PTMs incorporated into the NCP on enzymatic behavior. In theory, the enzy-
matic activity assay could be extended and performed with any desired enzyme and available
radio-labeled substrate, in the way we exemplified with GCN5 and Aurora B. In contrast to the
homogenous in-solution activity assay on NCPs developed by Nguyen et al. [115], immobiliza-
tion of the substrate (H3-NCP) allowed assay execution in a few steps, simple separation of
the enzyme as well as a surplus radio-labeled substrate after the reaction from immobilized
NCP. The remaining, immobilized NCPs can be used for further analysis of de novo PTMs.
Extending the assay by enzymatic release of NCP from the plate and analysis of de novo
modification degree by gel shift experiments [59;166] or by performing the experiment using
non-radioactive PTM label donor (AcCoA or ATP) on promising H3-PTM pattern and sub-
sequent analysis by mass spectrometry would identify the de novo modification degree and
site-dependence on the NCP pre-modification pattern. In a next step, it would be very inter-
esting to study modified nucleosome arrays with our developed system. However, a study
by Mittal et al. [167] pointed out, that an additional effect needs to be considered. They found
a varying acetylation degree of bead-bound tri-nucleosomes. The acetylation degree varies
depending on its position with respect to the linkage of the bead. This can mask the effect of
pre-modified nucleosome arrays on the activity of enzymes.
In contrast, we were not able to develop a robust binding assay using this experimental set up
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because of limited sensitivity and unstable assay performance. Moreover, the signal range of
strong binding and no binding was narrow (2-4 fold), thus intermediate binding events would
possibly not be recognized. New bead-based detection techniques, which have been im-
plemented successfully for analyzing methyltransferase activity and methyl binding domains
on histone peptides and full-length protein using ALPHAlisa and LANCE technology, might
provide a broader signal range because of the conditional signal development based on the
proximity of bound protein to its target [104–106].
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5 Summary and conclusion
Post-translational modifications of histones within nucleosomes regulate cell development,
cell maintenance and cellular response to external factors [168]. According to the histone
code hypothesis, each biologic reaction is encoded by a specific set of histone PTMs [79].
In order to decipher the histone code, we developed a platform in which ligation-ready nu-
cleosomes can be decorated with histone tails carrying PTMs of choice in a histone type
specific manner. In this study, we presented the development of ligation-ready nucleosomes
and histone type specific ligation of histone tails to H3 and H2A. For H3, Sortase A mediated
ligation was chosen as it has been shown before to function at the histone level. For H2A,
protein trans-splicing with an optimized mini-split intein (Ssp DnaB M86) was used. Ligation
ready nucleosome core particle were assembled with H3 and H2A carrying tags which al-
lowed a type selective approach. This meant for H3, truncation of the first 32 amino acids
and for H2A, N-terminal removal of the fist 18 amino acids and attachment of the split-intein
C-terminal part. Using these ligation strategies for H3 and H2A we were able to generate a
NCP library with 36 combinatoric modified H3 and 8 variations of H2A modifications, result-
ing in a library with a complexity of 288. However, for the development of binding and activity
assays only a 36 member H3-NCP library was used.
The interpretation of histone marks that lead eventually to the regulation of cell development,
cell maintenance and cellular response is carried out by effector proteins that ‘read’, ‘write’
or ‘erase’ histone PTMs. In order to gain insight in the ‘reading’ and ‘writing’ properties in de-
pendence of H3-NCP modifications, we present the stage of development of a binding assay
with fluorescence readout in 96-well format. As a ‘model’ protein was used in here, the well
characterized HP1β. In addition, we explored the H3-NCP modification dependent activity of
the histone acetyltransferase GCN5 and the kinase Aurora B in an enzymatic activity assay
with readout of incorporated radioisotopes.
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5 SUMMARY AND CONCLUSION
For the HP1-binding assay, we found specific recruitment of enhanced cyan fluorescent pro-
tein labeled HP1 (eCFP-HP1) by H3K9me2 over H3um-NCP in a proof of principle experi-
ment. This was detected by in-well fluorescence measurement and verified by western blot
analysis. Experiments on the whole H3-NCP library brought up the question: how can we
increase signal intensities and the ratio of eCFP-HP1 specific binding to H3K9me2- over
H3um-NCP? This has been addressed by optimization of experimental factors (buffer com-
position, incubation time, wash steps) and the use of brighter CFP variants. Despite the
optimizations in several directions we have been unable to develop a stable and robust bind-
ing assay.
The setup of an high-throughput screening of the impact of modified H3-NCP on the activity
of GCN5 and Aurora B presents an additional use of the immobilized NCP-library. Notice-
able, a stark increase in overall acetylation was observed in the presence of H3S28ph or
H3K27me2S28ph containing H3-NCP. This suggests a crucial role of PTMs in fine tuning the
enzymatic activity of GCN5. In contrast, for Aurora B we observed that pre-phosphorylated
H3-NCPs on both phosphorylation sites (H3S10ph/S28ph) were not a target for Aurora B
anymore. In addition, we found that NCPs unmodified at H3S10 were better substrates for
Aurora B than H3-NCPs containing pre-modified H3S10ph. This highlights the power of this
assay to detect enzyme inherent properties as a function of pre-modified NCPs.
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[6] V. Böhm, A. R. Hieb, A. J. Andrews, A. Gansen, A. Rocker, K. Tóth, K. Luger, and
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Figure 5.1: Impact of wash steps on eCFP-HP1 incubation with H3um- and H3K9me2-
NCP for 60 min
(A) Schematic representation of experimental set up: eCFP-HP1 was removed
after 60 min of incubation with n=3 wells per incubation time. Fluorescence mea-
surement took place in PBS with high salt and detergent containing wash steps
in between, as indicated. (B) Influence of washes on eCFP-HP1 recruitment
normalized with respect to NCP content for all replicates with 60 min incubation
time. The replicate H3um #1 shows resistance to all wash steps, thus this repli-












































































Figure 5.2: Assembly of wild type octamer and NCP
(A) Elution profile of size exclusion chromatography using HiLoad Superdex200
10/300 PG column for the purification of in vitro assembled wild type histone oc-
tamer. (B) Analysis of octamer input before concentration and after concentration
(Load) for injection onto the column, pooled octamer fractions were analyzed by
SDS-PAGE and subsequent CBB staining. (C) Native agarose gel electrophore-




















































Figure 5.3: Replicates of HAT and kinase assay
All replicates of HAT (A) and kinase (B) assay normalized to H3um-NCP (Un-
modified, ∗).
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